Document:

Exhibit 4.6

 

Form of Subordinated
Note

 

(FACE OF SECURITY)

 

[Each Global Security shall bear substantially
the following legend:

 

UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART
FOR SECURITIES IN DEFINITIVE REGISTERED FORM, THIS SECURITY MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF
THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR ANY SUCH
NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR DEPOSITARY. UNLESS THIS SECURITY IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE
OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER,
EXCHANGE OR PAYMENT, AND ANY SECURITY ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED
REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE
OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER
HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.]

 

[If the Security has original issue discount for
U.S. federal income tax purposes, insert tax legend:

 

[FOR PURPOSES OF SECTIONS 1272, 1273 AND 1275
OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED, AND THE RULES AND REGULATIONS THEREUNDER, THIS NOTE IS BEING ISSUED WITH ORIGINAL ISSUE
DISCOUNT; PLEASE CONTACT DAVID F. CARROLL, CHIEF FINANCIAL OFFICER, IVERIC BIO, INC., FIVE PENN PLAZA, SUITE 2372, NEW YORK, NEW YORK
10001, TELEPHONE: (212) 845-8200, TO OBTAIN INFORMATION REGARDING THE ISSUE PRICE, THE ISSUE DATE, THE AMOUNT OF ORIGINAL ISSUE DISCOUNT
AND THE YIELD TO MATURITY.]

 

     

     

    

 

IVERIC BIO, INC.

[ Title of Security ]

 

	No. [   ]	CUSIP No.:  [   ]
	 	[Common Code][ISIN]:   [    ]
	 	[$   ]

 

IVERIC bio, Inc., a Delaware
corporation (the “Issuer”, which term includes any successor corporation), for value received promises to pay to [If the
Security is a Global Security -- CEDE & CO.][If the Security is not a Global Security -- __________] or registered assigns,
the principal sum of __________ on __________,____ (the “Maturity Date”) [If the Security is to bear interest prior to
maturity, insert--, and to pay interest thereon from _____________ or from the most recent interest payment date to which interest
has been paid or duly provided for, [semiannually in arrears on ______ and ______ in each year], commencing _________, ____ (each,
an “Interest Payment Date”) at the rate of [___% per annum], until the principal hereof is paid or made available for
payment [If applicable insert--, and (to the extent that the payment of such interest shall be legally enforceable) at the rate
of ___% per annum on any overdue principal and on any overdue installment of interest]. The interest so payable, and punctually paid or
duly provided for, on any Interest Payment Date will, as provided in the Indenture (as defined below), be paid to the Holder in whose
name this Security (or one or more predecessor Securities) is registered at the close of business on the record date for such interest,
which shall be the _______ or ________ (whether or not a Business Day), as the case may be, next preceding such Interest Payment Date
(each, an “Interest Record Date”). Interest will be computed on the basis of [a 360-day year of twelve 30-day months].]

 

[If the Security is not to
bear interest prior to maturity, insert--The principal of this Security shall not bear interest except in the case of a default in
payment of principal upon acceleration, upon redemption or at maturity and, in each such case, the overdue principal of this Security
shall bear interest at the rate of ___% per annum (to the extent that the payment of such interest shall be legally enforceable), which
shall accrue from the date of such default in payment to the date payment of such principal has been made or duly provided for. Interest
on any overdue principal shall be payable on demand.]

 

Reference is made to the further
provisions set forth on the reverse of this Security contained herein, which will for all purposes have the same effect as if set forth
at this place.

 

     

     

    

 

IN WITNESS WHEREOF, the Issuer
has caused this Security to be signed manually or by facsimile by its duly authorized officer under its corporate seal.

 

	 	IVERIC BIO, INC.

 

	 	By:	 
	 	 	Name:	 
	 	 	Title:	 

 

	Attest:	 

 

	By:	 	 
	Name:	 	 
	Title:	 	 

 

This is one of the Securities
of the series designated herein and referred to in the within-mentioned Indenture.

 

Dated:  [   ]

 

____________, as Trustee

 

	 	By:	 
	 	 	Title:	 

 

     

     

    

 

(REVERSE OF
SECURITY)

 

IVERIC BIO,
INC.

 

[ Title of
Security ]

 

		1.	Indenture

 

This Security is one of a duly
authorized issue of debentures, notes or other evidence of indebtedness (hereinafter called the “Securities”) of the Issuer
of the series hereinafter specified, which series is initially limited in aggregate principal amount to [$]____________, all of
such Securities issued and to be issued under an Indenture dated as of ________, _____ (the “Indenture”) between the Issuer
and __________________________ as trustee (the “Trustee”). Capitalized terms herein are used as defined in the Indenture unless
otherwise indicated. The terms of the Securities include those stated in the Indenture and those made part of the Indenture by reference
to the Trust Indenture Act of 1939, as in effect on the date of the Indenture. The Securities are subject to all such terms, and Holders
are referred to the Indenture and the Trust Indenture Act for a statement of all such terms. To the extent permitted by applicable law,
in the event of any inconsistency between the terms of this Security and the terms of the Indenture, the terms of the Indenture shall
control.

 

This Security is one of a series
of Securities designated pursuant to the Indenture [and a [Supplemental Indenture] dated _____, _____, issued pursuant to Section
2.01 and Section 2.03 thereof (the “Supplemental Indenture”)] as ________________. The Securities are general unsecured obligations
of the Issuer. The Issuer may, subject to the provisions of the Indenture and applicable law, issue additional Securities of any series
under the Indenture.

 

		2.	Method of Payment.

 

The Issuer shall pay interest
on the Securities (except defaulted interest) to the persons who are the registered Holders at the close of business on the Interest Record
Date immediately preceding the Interest Payment Date notwithstanding any transfer or exchange of such Security subsequent to such Interest
Record Date and prior to such Interest Payment Date. Holders must surrender Securities to the Trustee to collect principal payments. The
Issuer shall pay Principal and interest in money of [the United States] that at the time of payment is legal tender for payment
of public and private debts. [However, the payments of interest, and any portion of the Principal (other than interest payable at maturity
or on any redemption or repayment date or the final payment of Principal) shall be made by the Paying Agent, upon receipt from the Issuer
of immediately available funds by __________ [a./p.m.], New York City time (or such other time as may be agreed to between the
Issuer and the Paying Agent or the Issuer), directly to a Holder (by Federal funds wire transfer or otherwise) if the Holder has delivered
written instructions to the Trustee 15 days prior to such payment date requesting that such payment will be so made and designating the
bank account to which such payments shall be so made and in the case of payments of principal surrenders the same to the Trustee in exchange
for a Security or Securities aggregating the same principal amount as the unredeemed principal amount of the Securities surrendered.]

 

     

     

    

 

		3.	Redemption.

 

[The Securities of this series
may be redeemed at any time [on or after ______, ______], as a whole or in part, at the option of the Issuer, upon mailing
notice of such redemption not less than 10 and not more than 60 days to the Holders of such Securities, at a redemption price equal to
___________.]

 

		4.	Paying Agent and Security Registrar

 

Initially, [the Trustee] will
act as Paying Agent and Security Registrar.  The Issuer may change any Paying Agent or Security Registrar without notice to
the Holders.

 

		5.	Denominations; Transfer; Exchange.

 

The Securities are in registered
form, without coupons, in denominations of [$1,000] and multiples of [$1,000]. A Holder shall register the transfer of or
exchange Securities in accordance with the Indenture. The Issuer may require a Holder, among other things, to furnish appropriate endorsements
and transfer documents and to pay certain transfer taxes or similar governmental charges payable in connection therewith as permitted
by the Indenture. [The Issuer need not register the transfer of or exchange (a) any Securities for a period of fifteen (15) days preceding
the first notice that such Securities are to be redeemed, or (b) any Securities selected, called or being called for redemption in whole
or in part, except, in the case of any Security to be redeemed in part, the portion thereof not to be so redeemed.]

 

		6.	Persons Deemed Owners.

 

The registered Holder of a Security
shall be treated as the owner of it for all purposes.

 

		7.	Unclaimed Funds.

 

If funds for the payment of principal
or interest remain unclaimed for two years, the Trustee and the Paying Agent will repay the funds to the Issuer. After that, all liability
of the Trustee and such Paying Agent with respect to such funds shall cease.

 

		8.	Defeasance.

 

The Indenture [as amended
by the Supplemental Indenture] contains provisions for defeasance at any time of (a) the entire indebtedness of the Issuer on this
Security and (b) certain restrictive covenants and the related Events of Default, upon compliance by the Issuer with certain conditions
set forth therein, which provisions [apply] to this Security.

 

		9.	Amendment; Supplement; Waiver.

 

Subject to certain
exceptions, the Securities of this series, [the Supplemental Indenture] and the provisions of the Indenture relating to the
Securities of this series may be amended or supplemented with the written consent of the Holders of at least a majority in aggregate
principal amount of the Securities of this series then outstanding, and any existing Default or Event of Default, other than the
non-payment of the principal amount of or interest on the Securities of this series, or compliance with certain provisions may be
waived with the consent of the Holders of a majority in aggregate principal amount of all the Securities of this series, then
outstanding. Without notice to or consent of any Holder, the parties thereto may amend or supplement the Indenture and the
Securities to, among other things, cure any ambiguity, defect or inconsistency, provide for uncertificated Securities in addition to
or in place of certificated Securities, or make any other change that does not adversely affect the rights of any Holder of a
Security.

 

    5 

     

    

 

		10.	Defaults and Remedies.

 

If an Event of Default (other
than certain bankruptcy Events of Default with respect to the Issuer) occurs and is continuing, the Trustee or the Holders of at least
25% in aggregate principal amount of Securities of this series then outstanding (voting as a separate class) by notice in writing to the
Issuer (and also to the Trustee if such notice is given by the Holders) may declare [the entire principal] of the Securities of
this series and the interest accrued thereon, if any, to be due and payable immediately in the manner and with the effect provided in
the Indenture. If a bankruptcy Event of Default with respect to the Issuer occurs and is continuing, then [the entire principal]
of the Securities then outstanding and interest accrued thereon, if any, shall become automatically due and payable immediately in the
manner and with the effect provided in the Indenture.  Holders of Securities may not enforce the Indenture or the Securities
except as provided in the Indenture. The Trustee is not obligated to enforce the Indenture or the Securities unless it has received indemnity
satisfactory to it. The Indenture permits, subject to certain limitations therein provided, Holders of a majority in aggregate principal
amount of the Securities then outstanding to direct the Trustee in its exercise of any trust or power. The Trustee may withhold from Holders
of Securities notice of certain continuing Defaults or Events of Default if it determines that withholding notice is in their interest.

 

		11.	Subordination.

 

Reference is made to the Indenture,
including, without limitation, provisions subordinating the payment of principal of and premium, if any, and interest on the Securities
to the prior payment in full of all Senior Indebtedness as defined in the Indenture.  Such further provisions shall for all
purposes have the same effect as though fully set forth at this place.

 

		12.	Trustee Dealings with Issuer.

 

The Trustee under the Indenture,
in its individual or any other capacity, may become the owner or pledgee of Securities and may otherwise deal with the Issuer as if it
were not the Trustee.

 

		13.	No Recourse Against Others.

 

No stockholder, director, officer,
employee or incorporator, past, present or future as such, of the Issuer or any predecessor or successor corporation thereof shall have
any liability for any obligation under the Securities or the Indenture or for any claim based on, in respect of or by reason of, such
obligations or their creation. Each Holder of a Security by accepting a Security waives and releases all such liability. The waiver and
release are part of the consideration for the issuance of the Securities.

 

    6 

     

    

 

		14.	Authentication.

 

This Security shall not be valid
until the Trustee manually signs the certificate of authentication on this Security.

 

		15.	Abbreviations and Defined Terms.

 

Customary abbreviations may be
used in the name of a Holder of a Security or an assignee, such as: TEN COM (= tenants in common), TEN ENT (= tenants by the entireties),
JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= Custodian), and U/G/M/A (= Uniform Gifts to
Minors Act).

 

		16.	CUSIP Numbers.

 

Pursuant to a recommendation
promulgated by the Committee on Uniform Security Identification Procedures, the Issuer has caused CUSIP numbers to be printed on the Securities
as a convenience to the Holders of the Securities. No representation is made as to the accuracy of such numbers as printed on the Securities
and reliance may be placed only on the other identification numbers printed hereon.

 

		17.	Governing Law.

 

The laws of the State of New
York shall govern the Indenture and this Security thereof, and for all purposes this Security shall be governed by and construed in accordance
with the laws of such State without regard to any principle of conflict of laws that would require or permit the application of the laws
of any other jurisdiction, except as may otherwise be required by mandatory provisions of law.

 

    7 

     

    

 

ASSIGNMENT
FORM

 

I or we assign and transfer this
Security to

 

	 
	(Print or type name, address and zip code of assignee or transferee)
	 
	 
	(Insert Social Security or other identifying number of assignee or transferee)

 

	 	and irrevocably appoint ______________________________________________

                                                     agent to transfer this Security on the books of the Issuer.  The agent may

                                                     substitute another to act for him.
	 

 

	Dated:	 	 	Signed:	 
	 	 	 	 	(Signed exactly as name

                                                          appears on the other side of

                                                          this Security)

 

	Signature	 
	Guarantee:	 	 
	 	Participant in a recognized Signature Guarantee Medallion Program (or other

                                                                 signature guarantor program reasonably acceptable to the Trustee)

 

    8Exhibit 10.1

 

 

Ladies and Gentlemen:

 

Greenrose Acquisition Corp,
a Delaware corporation (the “Issuer”), has entered into certain Business Combination Agreements (as defined in the
Definitive Proxy Statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on October 5, 2021 (the “Proxy”))
pursuant to which the Issuer intends to close on the Qualified Business Combinations (as defined in the Proxy), on the terms and subject
to the conditions set forth therein. The closing of the Qualified Business Combination (the “Closing”) is subject to
the satisfaction of a number of conditions. For the purposes hereof, the term “Closing Date” shall mean the date of
the Closing of the Qualified Business Combinations.

 

In order to help facilitate
the Closing, on the terms and subject to the conditions set forth herein, YA II PN, Ltd. (“Subscriber”) has agreed
to commit to purchase (collectively, the “Purchased Shares”) up to 1,000,000 shares Common Stock of the Issuer, $0.0001
par value per share (the “Common Stock”) in private transactions from the certain selling shareholders who are not
affiliated with the Issuer (the “Selling Shareholders”) and/or in open market transactions at a purchase price not
to exceed $10.14 per share. This letter agreement (the “Agreement”) is a condition to the Subscriber’s willingness
to commit to purchase the Purchased Shares.

 

In consideration of the foregoing
and the mutual acknowledgments, understandings, and agreements contained in this Agreement and for other good and valuable consideration,
the receipt and adequacy of which are hereby acknowledged, the Issuer and Subscriber hereby agree as follows:

 

1. Commitment
to Purchase Shares from Selling Shareholders. Subscriber agrees to, or to cause one or more of its affiliates to, to purchase an aggregate
of 1,000,000 shares of Common Stock from the Selling Shareholders in private and/or in open market transactions a purchase price not to
exceed $10.14 per share. The Issuer will use commercially reasonable efforts to identify and arrange for Selling Shareholders, which are
not affiliated with the Issuer, to enter into private transactions with the Subscriber for the sale of shares of Common Stock at a purchase
price not to exceed to $10.14 per share. The Subscriber purchases shall commence promptly after the Issuer publicly discloses in its SEC
filings all material information contained in this Agreement and shall end on or prior to 5:00 p.m. on October 25, 2021. Notwithstanding
anything to the contrary set forth herein, Subscriber shall only be obligated to purchase shares of Common Stock under this Section
1 that will be freely saleable, and not be subject to any restrictions on resale, by the Subscriber (i.e., Subscriber shall have no
obligated to purchase shares of Common Stock that would be deemed restricted and/or control shares for purposes of Rule 144 promulgated
under the Securities Act of 1933). For the avoidance of doubt, Subscriber shall not be obligated to purchase any shares of Common Stock
(either privately or in open market transactions) at purchase prices in excess of $10.14 per share.

 

     

     

    

 

2. Purchase
of Shares from Issuer. On the Closing Date, the Issuer shall issue and sell to the Subscriber, and the Subscriber shall purchase from
the Issuer, for the sum of $500 and other good and valuable consideration, an aggregate of 500,000 newly issued shares of Common Stock
(the “Newly Issued Shares”), on the terms and subject to the conditions, including the forfeiture provisions set forth
in Section 4, set forth in this Agreement. The Issuer shall, at its option, deliver to Subscriber either (i) a certificate registered
in Subscriber’s name representing the shares (the “Original Certificate”) or (ii) effect such delivery in book-entry
form. The Newly Issued Shares will be “restricted securities” and the Original Certificate or book-entry evidencing such Newly
Issued Shares will bear restrictive legends in accordance with Section 5 hereof.

3. Waiver
of Redemption Rights.  Subscriber acknowledges that it shall have certain rights with respect to the redemption of any Purchased
Shares to be purchased by Subscriber pursuant to Section 1 and 2 hereof, which rights of redemption are set forth in the Issuer’s
Amended and Restated Certificate of Incorporation (the “Charter”) and in connection with the Qualified Business Combinations
described in the Proxy. Subscriber covenants and agrees that neither it, nor any of its affiliates, shall:

 

(a) directly
or indirectly Transfer (as defined below) any of the Purchased Shares (other than to an investment fund or account managed by the same
investment manager as Subscriber), or any voting or economic interest therein, as of and following the date hereof through 5:00 p.m. eastern
time on October 25, 2021; and

 

(b) redeem,
elect to redeem or tender or submit for redemption any of the Purchased Shares, or otherwise exercise all or any portion of the redemption
rights under the Charter with respect to the Purchased Shares (the “Redemption Rights”), solely in connection with
the Qualified Business Combinations described in the Proxy or the special meeting of the stockholders of the Issuer to take place in connection
with the Qualified Business Combinations described in the Proxy.

 

For purposes hereof, “Transfer”
shall mean, with respect to Purchased Shares, the transfer, sale, offer, exchange, assignment, pledge (other than pursuant to standardized
pledge arrangements with Subscriber’s prime brokers) or other disposition.

 

4. Lock-Up
and Forfeiture of Newly Issued Shares. This Section 4 shall only apply to the Newly Issued Shares.

 

(a) Lock-Up
of Newly Issued Shares. The Subscriber agrees not to, during the period commencing on the Closing Date and ending on the 6-month anniversary
of the Closing Date (the “Lock-Up Period”) directly or indirectly Transfer (other than to an investment fund or account
managed by the same investment manager as Subscriber) any of the Newly Issued Shares, except as set forth below. At the end of each Lock-Up
Month (as defined below), such number of Shares shall be automatically released from the Lock-Up (“Released Shares”)
that is equal to:

 

166,667 Shares * ($11.50 –
Monthly VWAP) / Monthly VWAP

 

and the Transfer restrictions set forth herein
shall expire on the Released Shares, and the Subscriber (and/or its affiliates) shall be free to Transfer such Released Shares, at any
time, at its sole discretion, after the expiration of the applicable Lock-Up Month. Any proceeds received by the Subscriber from such
Transfer shall belong solely to Subscriber.

 

    2

     

    

 

For the purposes hereof,
the term “Monthly VWAP” shall mean the average of each of the daily Volume Weighted Average Prices of the Common Stock on
the primary market for the Common Stock as displayed by Bloomberg L.P. on each trading day during each Lock-Up Month. “Lock-Up Month”
shall mean each of the 6 consecutive one-month periods, the first such period beginning on the Closing Date and ending on the one-month
anniversary of the Closing Date, and each of the 5 subsequent one-month period, each such period beginning on the day immediately following
the end of the prior period and ending on the one-month anniversary of the end of the prior period. (By way of example, if the Closing
Date is October 27, 2021 the first Lock-Up Month shall be the period beginning on October 27, 2021 and ending on November 27, 2021, the
second Lock-Up Month shall be the period beginning on November 28, 2021 and ending on December 27, 2021, the third Lock-Up Month shall
be the period beginning on December 28, 2021 and ending on January 27, 2022, the fourth Lock-Up Month shall be the period beginning on
January 28, 2022 and ending on February 27, 2022, the fifth Lock-Up Month shall be the period beginning on February 28, 2022 and ending
on March 27, 2022, and the sixth Lock-Up Month shall be the period beginning on March 28, 2022 and ending on April 27, 2022. If the Monthly
VWAP for the first Lock-Up Month was $9.50, then at the end of the first Lock-Up Month 35,088 Newly Issued Shares (166,667 Newly Issued
Shares * ($11.50 - $9.50) / $9.50) shall be Released Shares.

 

(b) Forfeiture
of Newly Issued Shares. At the end of the Lock-Up Period, the Subscriber acknowledges and agrees that it shall forfeit any and all
rights to such number of Newly Issued Shares (up to an aggregate of 500,000 Newly Issued Shares, as such amount may be adjusted for share
splits, share dividends, reorganizations, recapitalizations and the like) as is equal to the difference between 500,000 Newly Issued Shares
and the sum of the Released Shares for each Lock-Up Month.

 

(c) Termination
of Rights as Stockholder. If any of the Newly Issued Shares are forfeited in accordance with this Section 4, then after
such time Subscriber (or its successor in interest), shall no longer have any rights as a holder of such forfeited Newly Issued Shares,
and the Issuer shall take such action as is appropriate to cancel such forfeited Newly Issued Shares.

 

(d) Share
Certificates. In the event an adjustment to the Original Certificates, if any, is required pursuant to this Section 4,
then Subscriber shall return such Original Certificates to the Issuer or its designated agent as soon as practicable upon its receipt
of notice from the Issuer advising Subscriber of such adjustment, following which a new certificate (the “New Certificate”),
if any, shall be issued in such amount representing the adjusted number of Newly Issued Shares held by Subscriber. The New Certificate,
if any, shall be returned to Subscriber as soon as practicable. Any such adjustment for any uncertificated securities held by Subscriber
shall be made in book-entry form.

 

5. Restrictive
Legends. Any certificates representing the Shares shall have endorsed thereon legends substantially as follows (and any book-entries
representing the Shares shall have similar notations):

 

“THE SECURITIES REPRESENTED HEREBY HAVE
NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS AND NEITHER THE SECURITIES NOR ANY INTEREST
THEREIN MAY BE OFFERED, SOLD, TRANSFERRED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER SUCH ACT OR SUCH LAWS OR AN EXEMPTION FROM REGISTRATION UNDER SUCH ACT AND SUCH LAWS WHICH, IN THE OPINION OF COUNSEL,
IS AVAILABLE.”

 

    3

     

    

 

6. Registration
Rights Agreement. In connection with the transactions contemplated hereby, on the date hereof, the Issuer shall execute and deliver
a registration rights agreement to the Subscriber substantially in the form attached hereto as Exhibit “A” providing that
the Issuer shall register the resale of the Newly Issued Shares by the Subscriber.

 

7.  Standby
Equity Purchase Agreement. In connection with the transactions contemplated hereby, on the date hereof, the parties shall enter into
a Standby Equity Purchase Agreement (the “SEPA”) substantially in the form attached hereto as Exhibit “B.”
As consideration for this commitment by the Subscriber made in the SEPA, the Issuer shall pay to the Subscriber a commitment fee in an
amount equal to $1,000,000 (the “Commitment Fee”), subject only to the Closing of the Qualified Business Combination.
The Issuer shall pay the Commitment Fee within 30 days of the Closing Date, at the option of the Issuer, in cash or by the issuance of
such number of shares of Common Stock as shall be equal to the Commitment Fee divided by the last closing price of the Common Stock on
the principal market as of the time such shares are issued to the Subscriber. The parties acknowledge and agree that this provision shall
supersede the obligations set forth in the SEPA term sheet dated October 7, 20201 and executed by the Issuer on October 10, 2021, which
term, sheet shall no longer have any force or effect.

 

8. Representations,
Warranties and Agreements.

 

(a) Subscriber’s
Representations, Warranties and Agreements. To induce the Issuer to issue the Newly Issued Shares to Subscriber, Subscriber hereby
represents and warrants to the Issuer and agrees with the Issuer as follows:

 

(i) Organization
and Authority. Subscriber is a limited liability company, duly organized, validly existing and in good standing under the laws of
the Cayman Islands, and possesses all requisite power and authority necessary to carry out the transactions contemplated by this Agreement.
This Agreement is a legal, valid and binding agreement of Subscriber, enforceable against Subscriber in accordance with its terms, except
as such enforceability may be limited by applicable bankruptcy, insolvency, fraudulent conveyance or similar laws affecting the enforcement
of creditors’ rights generally and subject to general principles of equity (regardless of whether enforcement is sought in a proceeding
at law or in equity).

 

(ii) No
Conflicts. The execution, delivery and performance of this Agreement and the consummation by Subscriber of the transactions contemplated
hereby do not violate, conflict with or constitute a default under (i) the formation and governing documents of Subscriber, (ii) any
agreement, indenture or instrument to which Subscriber is a party or (iii) any law, statute, rule, regulation, order, judgment or
decree to which Subscriber is subject.

 

(iii) No
Governmental Consents. No governmental, administrative or other third party consents or approvals are required, necessary or appropriate
on the part of Subscriber in connection with the transactions contemplated by this Agreement.

 

(iv) Experience,
Financial Capability and Suitability. Subscriber is sophisticated in financial matters and is able to evaluate the risks and benefits
of the investment in the Newly Issued Shares. Subscriber acknowledges that the Newly Issued Shares have not been registered under the
Securities Act of 1933, as amended (the “Securities Act”), and therefore cannot be sold unless subsequently registered
under the Securities Act or an exemption from such registration is available. Subscriber understands that it must bear the economic risk
of this investment until the Newly Issued Shares are sold pursuant to: (i) an effective registration statement under the Securities
Act or (ii) an exemption from registration available with respect to such sale. Subscriber is able to bear the economic risk of an
investment in the Newly Issued Shares for an indefinite period of time and to afford a complete loss of Subscriber’s investment
in the Newly Issued Shares.

 

    4

     

    

 

(v) No
Government Recommendation or Approval. Subscriber understands that no federal or state agency has passed upon or made any recommendation
or endorsement of the offering of the Newly Issued Shares.

 

(vi) Access
to Information; Independent Investigation. Prior to the execution of this Agreement, Subscriber has had the opportunity to ask questions
of and receive answers from representatives of the Issuer concerning an investment in the Issuer, as well as the financial condition,
business and prospects of the Issuer, and the opportunity to obtain additional information to verify the accuracy of all information so
obtained. In determining whether to make this investment, Subscriber has relied solely on Subscriber’s own knowledge and understanding
of the Issuer and its business based upon Subscriber’s own due diligence investigation. Subscriber understands that no person has
been authorized to make any representations other than as set forth in this Agreement and Subscriber has not relied on any other written
or oral representations relating to the financial condition, business and prospects of the Issuer in making its investment decision.

 

(vii) Investment
Representations. Subscriber represents that it is an “accredited investor” as such term is defined in Rule 501(a) of Regulation
D under the Securities Act and acknowledges the sale contemplated hereby is being made in reliance on the private placement exemption
in Section 4(a)(2) of the Securities Act and/or said Regulation D and similar exemptions under state law. Subscriber is purchasing
the Newly Issued Shares solely for investment purposes, for Subscriber’s own account and not for the account or benefit of any other
person, and not with a view towards the distribution or dissemination thereof. Subscriber did not decide to enter into this Agreement
as a result of any general solicitation or general advertising within the meaning of Rule 502 under the Securities Act.

 

(viii) Restrictions
on Transfer; Shell Company. Subscriber understands the Newly Issued Shares are being offered in a transaction not involving a public
offering within the meaning of the Securities Act. Subscriber understands the Newly Issued Shares will be “restricted securities”
within the meaning of Rule 144(a)(3) under the Securities Act, and Subscriber understands that the certificates or book-entries representing
the Newly Issued Shares will contain a legend or notation in respect of such restrictions. If, in the future, Subscriber decides to offer,
resell, pledge or otherwise transfer the Newly Issued Shares, such Newly Issued Shares may be offered, resold, pledged or otherwise transferred
only pursuant to: (i) an effective registration statement under the Securities Act or (ii) an exemption from registration available
with respect to such sale. Subscriber agrees that if any transfer of its Newly Issued Shares or any interest therein is proposed to be
made, as a condition precedent to any such transfer, Subscriber may be required to deliver to the Issuer an opinion of counsel satisfactory
to the Issuer. Absent registration or available exemption, Subscriber agrees not to resell the Newly Issued Shares. Subscriber further
acknowledges that because the Issuer is a shell company, Rule 144 may not be available to Subscriber for the resale of the Newly Issued
Shares until one year following consummation of the initial business combination of the Issuer, despite the release or waiver of any contractual
transfer restrictions.

 

(b) Issuer’s
Representations, Warranties and Agreements. To induce Subscriber to purchase the Newly Issued Shares, the Issuer hereby represents
and warrants to Subscriber and agrees with Subscriber as follows:

 

(i) Organization
and Authority. The Issuer is a corporation, duly organized, validly existing and in good standing under the laws of the State of Delaware,
and possesses all requisite power and authority necessary to carry out the transactions contemplated by this Agreement. This Agreement
is a legal, valid and binding agreement of the Issuer, enforceable against the Issuer in accordance with its terms, except as such enforceability
may be limited by applicable bankruptcy, insolvency, fraudulent conveyance or similar laws affecting the enforcement of creditors’
rights generally and subject to general principles of equity (regardless of whether enforcement is sought in a proceeding at law or in
equity).

 

(ii) No
Conflicts. The execution, delivery and performance of this Agreement and the consummation by the Issuer of the transactions contemplated
hereby do not violate, conflict with or constitute a default under (i) the formation and governing documents of the Issuer, (ii) any
agreement, indenture or instrument to which the Issuer is a party or (iii) any law, statute, rule, regulation, order, judgment or
decree to which the Issuer is subject.

 

    5

     

    

 

(iii) No
Governmental Consents. No governmental, administrative or other third party consents or approvals are required, necessary or appropriate
on the part of the Issuer in connection with the transactions contemplated by this Agreement.

 

(iv) Title
to Securities. Upon issuance in accordance with, and payment pursuant to, the terms hereof, the Newly Issued Shares will be duly and
validly issued, fully paid and nonassessable. Upon issuance in accordance with, and payment pursuant to, the terms hereof, Subscriber
will have or receive good title to the Newly Issued Shares, free and clear of all liens, claims and encumbrances of any kind, other than
(a) transfer restrictions hereunder and other agreements to which the Newly Issued Shares may become subject, (b) transfer restrictions
under federal and state securities laws, and (c) liens, claims or encumbrances imposed due to the actions of Subscriber.

 

(v) No
Adverse Actions. There are no actions, suits, investigations or proceedings pending, threatened against or affecting the Issuer
which: (i) seek to restrain, enjoin, prevent the consummation of or otherwise affect the transactions contemplated by this Agreement
or (ii) question the validity or legality of any such transactions or seeks to recover damages or to obtain other relief in connection
with any such transactions.

 

(vi) Trust
Account. The per-share amount that the Issuer will distribute to investors who redeem their shares prior to the consummation of the
Qualified Business Combination, including interest, is estimated to be approximately $10.14.

 

(viI)
Disclosure of Transactions and Other Material Information. Within 1 day after the date of this Agreement, the Issuer shall file
a current report on Form 8-K describing all the material terms of the transactions contemplated herein in the form required by the 1934
Act and attaching all the material exhibits (including, without limitation, this Agreement and all schedules to this Agreement) (including
all attachments, the “Current Report”). From and after the filing of the Current Report, the Issuer shall have disclosed
all material, non-public information (if any) provided to the Subscriber by the Issuer or any of its subsidiaries, targets, or any of
their respective officers, directors, employees or agents in connection with the transactions contemplated herein. In addition, effective
upon the filing of the Current Report, the Issuer acknowledges and agrees that any and all confidentiality or similar obligations with
respect to the transactions contemplated herein under any agreement, whether written or oral, between the Issuer, any of its subsidiaries,
targets, or any of their respective officers, directors, affiliates, employees or agents, on the one hand, and the Subscriber or any
of their affiliates, on the other hand, shall terminate. The Issuer shall not, and the Issuer shall cause each of its subsidiaries, targets,
and each of its and their respective officers, directors, employees and agents not to, provide the Subscriber with any material, non-public
information regarding the Issuer or any of its subsidiaries or targets from and after the date hereof without the express prior written
consent of the Subscriber (which may be granted or withheld in the Subscriber’s sole discretion).

 

9. Miscellaneous.

 

(a) This
Agreement constitutes the entire agreement, and supersedes all other prior agreements, understandings, representations and warranties,
both written and oral, among the parties, with respect to the subject matter hereof.

 

(b) Except as otherwise provided
herein, this Agreement shall be binding upon, and inure to the benefit of the parties hereto and their heirs, executors, administrators,
successors, legal representatives, and permitted assigns, and the agreements, representations, warranties, covenants and acknowledgments
contained herein shall be deemed to be made by, and be binding upon, such heirs, executors, administrators, successors, legal representatives
and permitted assigns.  

 

(c) If any provision of this Agreement shall be invalid, illegal or unenforceable, the validity, legality
or enforceability of the remaining provisions of this Agreement shall not in any way be affected or impaired thereby and shall continue
in full force and effect.

 

    6

     

    

 

(d) This
Agreement may be executed in two (2) or more counterparts (including by electronic means), all of which shall be considered one and
the same agreement and shall become effective when signed by each of the parties and delivered to the other parties, it being understood
that all parties need not sign the same counterpart.

 

(e) Any
notice or communication required or permitted hereunder shall be in writing and either delivered personally, emailed, sent by overnight
mail via a reputable overnight carrier, or sent by certified or registered mail, postage prepaid, and shall be deemed to be given and
received (a) when so delivered personally, (b)  when sent, with no mail undeliverable or other rejection notice, if sent by
email, or (c) five (5) business days after the date of mailing to the address below or to such other address or addresses as such
person may hereafter designate by notice given hereunder:

 

(i) if to Subscriber,
to such address or addresses set forth on the signature page hereto;

 

(ii) if to the Issuer, to:

 

Greenrose
Acquisition Corp.

111
Broadway

Amityville, NY 11701Attention: William F. Harley III

Email: Mickey@greenrosecorp.c

 

with a required copy to (which copy shall not constitute
notice):

 

Tarter Krinsky & Drogin

1350 Broadway

New York, NY 10018

Attention: Guy Molinari

Email: gmolinari@tarterkrinsky

  

(f) This
Agreement, and all claims or causes of action based upon, arising out of, or related to this Agreement or the transactions contemplated
hereby, shall be governed by, and construed in accordance with, the Laws of the State of New York, without giving effect to principles
or rules of conflict of laws to the extent such principles or rules would require or permit the application of laws of another jurisdiction.

 

(g) Any
claim, action, suit, assessment, arbitration or proceeding based upon, arising out of or related to this Letter Agreement, or the transactions
contemplated hereby, shall be brought in the Supreme Court of the State of New York or, if such court declines to exercise jurisdiction,
any federal or state court located in the State of New York, County of New York, and each of the parties irrevocably submits to the exclusive
jurisdiction of each such court in any such claim, action, suit, assessment, arbitration or proceeding, waives any objection it may now
or hereafter have to personal jurisdiction, venue or to convenience of forum, agrees that all claims in respect of such claim, action,
suit, assessment, arbitration or proceeding shall be heard and determined only in any such court, and agrees not to bring any claim, action,
suit, assessment, arbitration or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby in any
other court. Nothing herein contained shall be deemed to affect the right of any party to serve process in any manner permitted by law,
or to commence legal proceedings or otherwise proceed against any other party in any other jurisdiction, in each case, to enforce judgments
obtained in any claim, action, suit, assessment, arbitration or proceeding brought pursuant to this paragraph. EACH OF THE PARTIES HERETO
HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY ACTION BASED UPON, ARISING OUT OF OR RELATED TO THIS LETTER AGREEMENT
OR THE TRANSACTIONS CONTEMPLATED HEREBY.

 

[Signature page follows.]

 

    7

     

    

 

IN WITNESS WHEREOF,
each of the Issuer and Subscriber has executed or caused this Letter Agreement to be executed by its duly authorized representative as
of the date set forth above.

 

	 	ISSUER:
	 	 
	 	GREENROSE ACQUISITION CORP
	 	 	 
	 	By:	/s/ William F. Harley III
	 	Name: 	William F. Harley III
	 	Title:	Chief Executive Officer

 

SUBSCRIBER:

 

Accepted and Agreed:

YA II PN, LTD.

 

	By:	Yorkville Advisors Global, LP	 
	Its:	Investment Manager	 
	 	 	 	 
		By:	Yorkville Advisors Global II, LLC	 
		Its:	General Partner	 
	 	 	 	 
	 	By:	/s/ Matt Beckman	 
	 	Name: 	Matt Beckman	 
	 	Title:	Member	 

 

	Address for Notices: 	1012 Springfield Avenue,

 Mountainside, NJ 07092	 

 

	Attention: 	Legal Department	 

 

	Email: 	Legal@yorkvilleadvisos.com	 

 

    8

     

    

 

EXHIBIT A

 

REGISTRATION RIGHTS AGREEMENT

 

THIS REGISTRATION RIGHTS
AGREEMENT (this “Agreement”), dated as of October 20, 2021 by and among GREENROSE ACQUISITION CORP., INC.,
a Delaware corporation (the “Company”), and YA II PN, Ltd., a Cayman Islands exempt limited partnership
(the “Investor”).

 

WHEREAS:

 

A. In
connection with the Letter Agreement by and among the parties hereto of even date herewith (the “Letter Agreement”),
the Company has agreed, upon the terms and subject to the conditions of the Letter Agreement, to issue and sell to the Investor 500,000
shares (the “Newly Issued Shares”) of the Company’s common stock, par value $0.0001 (the “Common Stock”).
Capitalized terms not defined herein shall have the meaning ascribed to them in the Letter Agreement.

 

B. To
induce the Investors to execute and deliver the Letter Agreement, the Company has agreed to provide certain registration rights under
the Securities Act of 1933, as amended, and the rules and regulations thereunder, or any similar successor statute (collectively,
the “Securities Act”), and applicable state securities laws and other rights as provided for herein.

 

NOW, THEREFORE, in
consideration of the premises and the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the Company and the Investors hereby agree as follows:

 

1. DEFINITIONS.

 

As used in this Agreement,
the following terms shall have the following meanings:

 

(a) “Effectiveness
Deadline” means, with respect to a Registration Statement filed hereunder, the 45th calendar day following the filing date thereof,
provided, however, in the event the Company is notified by the SEC that the Registration Statement, as defined below, will not be reviewed
or is no longer subject to further review and comments, the Effectiveness Deadline as to the Registration Statement shall be the fifth
calendar day following the date on which the Company is so notified if such date precedes the date required above.

 

(b) “Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

(c) “Filing
Deadline” means, with respect to the Registration Statement required hereunder, the 30th calendar day following the date of
issuance of the Newly Issued Shares.

 

(d) “Person”
means a corporation, a limited liability company, an association, a partnership, an organization, a business, an individual, a governmental
or political subdivision thereof or a governmental agency.

 

    A-1

     

    

 

(e) “Prospectus”
means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information previously
omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated under the Securities
Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of any portion of the Registrable
Securities covered by a Registration Statement, and all other amendments and supplements to the Prospectus, including post-effective amendments,
and all material incorporated by reference or deemed to be incorporated by reference in such Prospectus.

 

(f) “Registrable
Securities” means all of (i) the Newly Issued Shares, and (ii) any shares of Common Stock issued or issuable with respect to
any shares described in subsections (i) above by way of any stock split, stock dividend or other distribution, recapitalization or similar
event or otherwise.

 

(g) “Registration
Statement” means any registration statement of the Company, including the Prospectus, amendments and supplements to such registration
statement or Prospectus, including post-effective amendments, all exhibits thereto, and all material incorporated by reference or deemed
to be incorporated by reference in such registration statement.

 

(h) “Rule
144” means Rule 144 under the Securities Act or any successor rule thereto.

 

(i) “Rule
415” means Rule 415 promulgated by the SEC pursuant to the Securities Act, as such Rule may be amended from time to time, or
any similar rule or regulation hereafter adopted by the SEC having substantially the same purpose and effect as such Rule.

 

(j) “SEC”
means the U.S. Securities and Exchange Commission or any other federal agency administering the Securities Act and the Exchange Act at
the time.

 

(k) “Securities
Act” shall have the meaning set forth in the Recitals above.

 

2. REGISTRATION.

 

(a) The
Company’s registration obligations set forth in this Section 2 including its obligations to file a Registration Statement, obtain
effectiveness of the Registration Statement, and maintain the continuous effectiveness of Registration Statement that have been declared
effective shall begin on the date hereof and continue until all the Registrable Securities have been sold or may permanently be sold without
any restrictions pursuant to Rule 144, as determined by the counsel to the Company pursuant to a written opinion letter to such effect,
addressed and acceptable to the Company’s transfer agent and the Investor (the “Registration Period”).

 

(b) Subject
to the terms and conditions of this Agreement, the Company shall (i) on or prior to the Filing Deadline, prepare and file with the SEC
an initial Registration Statement on Form S-1 or any successor form thereto covering the resale by the Investor of the Registrable Securities.
The Registration Statement shall contain the “Selling Stockholders” and “Plan of Distribution” sections
in the form appropriate for such a transaction. The Company shall use its best efforts to have the Registration Statement declared effective
by the SEC as soon as practicable, but in no event later than the Effectiveness Deadline. By 9:30 am on the business day following the
date of effectiveness, the Company shall file with the SEC in accordance with Rule 424 under the 1933 Act the final Prospectus to be used
in connection with sales pursuant to such Registration Statement. Prior to the filing of the Registration Statement with the SEC, the
Company shall furnish a draft of the Registration Statement to the Investor for their review and comment. The Investor shall furnish comments
on the Registration Statement to the Company within twenty-four (24) hours of the receipt thereof from the Company.

 

    A-2

     

    

 

(c) During
the Registration Period, the Company shall (i) promptly prepare and file with the SEC such amendments (including post-effective amendments)
and supplements to the Registration Statement and the Prospectus used in connection with the Registration Statement, which Prospectus
is to be filed pursuant to Rule 424 promulgated under the Securities Act, as may be necessary to keep such Registration Statement effective
at all times during the Registration Period, (ii) cause the related Prospectus to be amended or supplemented by any required Prospectus
supplement (subject to the terms of this Agreement), and as so supplemented or amended to be filed pursuant to Rule 424; (iii) respond
as promptly as reasonably possible to any comments received from the SEC with respect to a Registration Statement or any amendment thereto
and as promptly as reasonably possible provide the Investors true and complete copies of all correspondence from and to the SEC relating
to a Registration Statement (provided that the Company may excise any information contained therein which would constitute material non-public
information as to any Investor which has not executed a confidentiality agreement with the Company); and (iv) comply with the provisions
of the Securities Act with respect to the disposition of all Registrable Securities of the Company covered by such Registration Statement
until such time as all of such Registrable Securities shall have been disposed of in accordance with the intended methods of disposition
by the seller or sellers thereof as set forth in such Registration Statement. In the case of amendments and supplements to a Registration
Statement which are required to be filed pursuant to this Agreement (including pursuant to this Section 2(c)) by reason of the Company’s
filing a report on Form 10-K, Form 10-Q, or Form 8-K or any analogous report under the Securities Exchange Act, the Company shall incorporate
such report by reference into the Registration Statement, if applicable, or shall file such amendments or supplements with the SEC on
the same day on which the Exchange Act report is filed which created the requirement for the Company to amend or supplement the Registration
Statement.

 

3. RELATED
OBLIGATIONS.

 

(a) The
Company shall, not less than two (2) Trading Days prior to the filing of each Registration Statement and not less than one (1) Trading
Day prior to the filing of any related amendments and supplements to all Registration Statements (except for annual reports on Form 10-K),
furnish to each Investor copies of all such documents proposed to be filed, which documents (other than those incorporated or deemed to
be incorporated by reference) will be subject to the reasonable and prompt review of such Investors, The Company shall not file a Registration
Statement or any such Prospectus or any amendments or supplements thereto to which the Investors shall reasonably object in good faith;
provided that, the Company is notified of such objection in writing no later than two (2) Trading Days after the Investors have
been so furnished copies of a Registration Statement.

 

    A-3

     

    

 

(b) The
Company shall furnish to each Investor whose Registrable Securities are included in any Registration Statement, without charge, (i) at
least one (1) copy of such Registration Statement as declared effective by the SEC and any amendment(s) thereto, including financial statements
and schedules, all documents incorporated therein by reference, all exhibits and each preliminary prospectus, (ii) ten (10) copies of
the final prospectus included in such Registration Statement and all amendments and supplements thereto (or such other number of copies
as such Investor may reasonably request) and (iii) such other documents, which are not publicly available through EDGAR, as such Investor
may reasonably request from time to time in order to facilitate the disposition of the Registrable Securities owned by such Investor.

 

(c) The
Company shall use its best efforts to (i) register and qualify the Registrable Securities covered by a Registration Statement under such
other securities or “blue sky” laws of such jurisdictions in the United States as any Investor reasonably requests, (ii) prepare
and file in those jurisdictions, such amendments (including post-effective amendments) and supplements to such registrations and qualifications
as may be necessary to maintain the effectiveness thereof during the Registration Period, (iii) take such other actions as may be necessary
to maintain such registrations and qualifications in effect at all times during the Registration Period, and (iv) take all other actions
reasonably necessary or advisable to qualify the Registrable Securities for sale in such jurisdictions; provided, however, that the Company
shall not be required in connection therewith or as a condition thereto to (w) make any change to its articles of incorporation or by-laws,
(x) qualify to do business in any jurisdiction where it would not otherwise be required to qualify but for this Section 3(c), (y) subject
itself to general taxation in any such jurisdiction, or (z) file a general consent to service of process in any such jurisdiction. The
Company shall promptly notify each Investor who holds Registrable Securities of the receipt by the Company of any notification with respect
to the suspension of the registration or qualification of any of the Registrable Securities for sale under the securities or “blue
sky” laws of any jurisdiction in the United States or its receipt of actual notice of the initiation or threat of any proceeding
for such purpose.

 

(d) As
promptly as practicable after becoming aware of such event or development, the Company shall notify each Investor in writing of the happening
of any event as a result of which the Prospectus included in a Registration Statement, as then in effect, includes an untrue statement
of a material fact or omission to state a material fact required to be stated therein or necessary to make the statements therein, in
light of the circumstances under which they were made, not misleading (provided that in no event shall such notice contain any material,
nonpublic information), and promptly prepare a supplement or amendment to such Registration Statement to correct such untrue statement
or omission, and deliver ten (10) copies of such supplement or amendment to each Investor. The Company shall also promptly notify each
Investor in writing (i) when a Prospectus or any Prospectus supplement or post-effective amendment has been filed, and when a Registration
Statement or any post-effective amendment has become effective (notification of such effectiveness shall be delivered to each Investor
by facsimile on the same day of such effectiveness), (ii) of any request by the SEC for amendments or supplements to a Registration Statement
or related prospectus or related information, and (iii) of the Company’s reasonable determination that a post-effective amendment
to a Registration Statement would be appropriate.

 

    A-4

     

    

 

(e) The
Company shall use its best efforts to prevent the issuance of any stop order or other suspension of effectiveness of a Registration Statement,
or the suspension of the qualification of any of the Registrable Securities for sale in any jurisdiction within the United States of America
and, if such an order or suspension is issued, to obtain the withdrawal of such order or suspension at the earliest possible moment and
to notify each Investor who holds Registrable Securities being sold of the issuance of such order and the resolution thereof or its receipt
of actual notice of the initiation or threat of any proceeding for such purpose.

 

(f) The
Company shall use its best efforts to cause all the Registrable Securities to be listed on each securities exchange on which the Common
Stock is then listed. The Company shall pay all fees and expenses in connection with satisfying its obligation under this Section 3(i).

 

(g) The
Company shall cooperate with the holders of the Registrable Securities to facilitate the timely preparation and delivery of certificates
representing the Registrable Securities to be sold pursuant to such Registration Statement or Rule 144 free of any restrictive legends
and representing such number of shares of Common Stock and registered in such names as the holders of the Registrable Securities may reasonably
request a reasonable period of time prior to sales of Registrable Securities pursuant to such Registration Statement or Rule; provided,
that the Company may satisfy its obligations hereunder without issuing physical stock certificates through the use of The Depository Trust
Company's Direct Registration System.

 

(h) Within
two (2) business days after a Registration Statement which covers Registrable Securities is declared effective by the SEC, the Company
shall deliver, and shall cause legal counsel for the Company to deliver, to the transfer agent for such Registrable Securities (with copies
to the Investor whose Registrable Securities are included in such Registration Statement) confirmation that such Registration Statement
has been declared effective by the SEC.

 

(i) The
Company shall take all other reasonable actions necessary to expedite and facilitate disposition by each Investor of Registrable Securities
pursuant to a Registration Statement.

 

4. OBLIGATIONS
OF THE INVESTORS.

 

(a) The
Investor agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described in Section 3(d)
such Investor will immediately discontinue disposition of Registrable Securities pursuant to any Registration Statement covering such
Registrable Securities until the Investor’s receipt of the copies of the supplemented or amended prospectus contemplated by Section
3(d) or receipt of notice that no supplement or amendment is required.

 

(b) Registrable

 

    A-5

     

    

 

5. EXPENSES
OF REGISTRATION.

 

All expenses incurred by the
Company in complying with its obligations pursuant to this Agreement and in connection with the registration and disposition of Registrable
Securities shall be paid by the Company, including, without limitation, all registration, listing and qualifications fees, printers, fees
and expenses of the Company's counsel and accountants (except legal fees of Investor’s counsel associated with the review of the
Registration Statement).

 

6. INDEMNIFICATION.

 

With respect to Registrable
Securities which are included in a Registration Statement under this Agreement:

 

(a) To
the fullest extent permitted by law, the Company will, and hereby does, indemnify, hold harmless and defend the Investor, the directors,
officers, partners, employees, agents, representatives of, and each Person, if any, who controls any Investor within the meaning of the
Securities Act or the Exchange Act (each, an “Indemnified Person”), against any losses, claims, damages, liabilities,
judgments, fines, penalties, charges, costs, reasonable attorneys’ fees, amounts paid in settlement or expenses, joint or several
(collectively, “Claims”) incurred in investigating, preparing or defending any action, claim, suit, inquiry, proceeding,
investigation or appeal taken from the foregoing by or before any court or governmental, administrative or other regulatory agency, body
or the SEC, whether pending or threatened, whether or not an indemnified party is or may be a party thereto (“Indemnified Damages”),
to which any of them may become subject insofar as such Claims (or actions or proceedings, whether commenced or threatened, in respect
thereof) arise out of or are based upon: (i) any untrue statement or alleged untrue statement of a material fact in a Registration Statement
or any post-effective amendment thereto or in any filing made in connection with the qualification of the offering under the securities
or other “blue sky” laws of any jurisdiction in which Registrable Securities are offered (“Blue Sky Filing”),
or the omission or alleged omission to state a material fact required to be stated therein or necessary to make the statements therein
not misleading; (ii) any untrue statement or alleged untrue statement of a material fact contained in any final prospectus (as amended
or supplemented, if the Company files any amendment thereof or supplement thereto with the SEC) or the omission or alleged omission to
state therein any material fact necessary to make the statements made therein, in light of the circumstances under which the statements
therein were made, not misleading; or (iii) any violation or alleged violation by the Company of the Securities Act, the Exchange Act,
any other law, including, without limitation, any state securities law, or any rule or regulation there under relating to the offer or
sale of the Registrable Securities pursuant to a Registration Statement (the matters in the foregoing clauses (i) through (iii) being,
collectively, “Violations”). The Company shall reimburse the Investors and each such controlling person promptly as
such expenses are incurred and are due and payable, for any legal fees or disbursements or other reasonable expenses incurred by them
in connection with investigating or defending any such Claim. Notwithstanding anything to the contrary contained herein, the indemnification
agreement contained in this Section 6(a): (x) shall not apply to a Claim by an Indemnified Person arising out of or based upon a Violation
which occurs in reliance upon and in conformity with information furnished in writing to the Company by such Indemnified Person expressly
for use in connection with the preparation of the Registration Statement or any such amendment thereof or supplement thereto; (y) shall
not be available to the extent such Claim is based on a failure of the Investor to deliver or to cause to be delivered the prospectus
made available by the Company, if such prospectus was timely made available by the Company pursuant to Section 3(c); and (z) shall
not apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written consent of the Company,
which consent shall not be unreasonably withheld. Such indemnity shall remain in full force and effect regardless of any investigation
made by or on behalf of the Indemnified Person.

 

    A-6

     

    

 

(b) In
connection with a Registration Statement, the Investor agrees to severally and not jointly indemnify, hold harmless and defend, to the
same extent and in the same manner as is set forth in Section 6(a), the Company, each of its directors, each of its officers, employees,
representatives, or agents and each Person, if any, who controls the Company within the meaning of the Securities Act or the Exchange
Act (each an “Indemnified Party”), against any Claim or Indemnified Damages to which any of them may become subject,
under the Securities Act, the Exchange Act or otherwise, insofar as such Claim or Indemnified Damages arise out of or is based upon any
Violation, in each case to the extent, and only to the extent, that such Violation occurs in reliance upon and in conformity with written
information furnished to the Company by such Investor expressly for use in connection with such Registration Statement; and, subject to
Section 6(d), such Investor will reimburse any legal or other expenses reasonably incurred by them in connection with investigating or
defending any such Claim; provided, however, that the indemnity agreement contained in this Section 6(b) and the agreement with respect
to contribution contained in Section 7 shall not apply to amounts paid in settlement of any Claim if such settlement is effected without
the prior written consent of such Investor, which consent shall not be unreasonably withheld; provided, further, however, that the Investor
shall be liable under this Section 6(b) for only that amount of a Claim or Indemnified Damages as does not exceed the net proceeds to
such Investor as a result of the sale of Registrable Securities pursuant to such Registration Statement. Such indemnity shall remain in
full force and effect regardless of any investigation made by or on behalf of such Indemnified Party. Notwithstanding anything to the
contrary contained herein, the indemnification agreement contained in this Section 6(b) with respect to any prospectus shall not inure
to the benefit of any Indemnified Party if the untrue statement or omission of material fact contained in the prospectus was corrected
and such new prospectus was delivered to each Investor prior to such Investor’s use of the prospectus to which the Claim relates.

 

(c) Promptly
after receipt by an Indemnified Person or Indemnified Party under this Section 6 of notice of the commencement of any action or proceeding
(including any governmental action or proceeding) involving a Claim, such Indemnified Person or Indemnified Party shall, if a Claim in
respect thereof is to be made against any indemnifying party under this Section 6, deliver to the indemnifying party a written notice
of the commencement thereof, and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying party
so desires, jointly with any other indemnifying party similarly noticed, to assume control of the defense thereof with counsel mutually
satisfactory to the indemnifying party and the Indemnified Person or the Indemnified Party, as the case may be; provided, however, that
an Indemnified Person or Indemnified Party shall have the right to retain its own counsel with the fees and expenses of not more than
one (1) counsel for such Indemnified Person or Indemnified Party to be paid by the indemnifying party, if, in the reasonable opinion of
counsel retained by the indemnifying party, the representation by such counsel of the Indemnified Person or Indemnified Party and the
indemnifying party would be inappropriate due to actual or potential differing interests between such Indemnified Person or Indemnified
Party and any other party represented by such counsel in such proceeding. The Indemnified Party or Indemnified Person shall cooperate
fully with the indemnifying party in connection with any negotiation or defense of any such action or claim by the indemnifying party
and shall furnish to the indemnifying party all information reasonably available to the Indemnified Party or Indemnified Person which
relates to such action or claim. The indemnifying party shall keep the Indemnified Party or Indemnified Person fully apprised at all times
as to the status of the defense or any settlement negotiations with respect thereto. No indemnifying party shall be liable for any settlement
of any action, claim or proceeding effected without its prior written consent; provided, however, that the indemnifying party shall not
unreasonably withhold, delay or condition its consent. No indemnifying party shall, without the prior written consent of the Indemnified
Party or Indemnified Person, consent to entry of any judgment or enter into any settlement or other compromise which does not include
as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified Party or Indemnified Person of a release
from all liability in respect to such claim or litigation. Following indemnification as provided for hereunder, the indemnifying party
shall be subrogated to all rights of the Indemnified Party or Indemnified Person with respect to all third parties, firms or corporations
relating to the matter for which indemnification has been made. The failure to deliver written notice to the indemnifying party within
a reasonable time of the commencement of any such action shall not relieve such indemnifying party of any liability to the Indemnified
Person or Indemnified Party under this Section 6, except to the extent that the indemnifying party is prejudiced in its ability to defend
such action.

 

    A-7

     

    

 

(d) The
indemnification required by this Section 6 shall be made by periodic payments of the amount thereof during the course of the investigation
or defense, as and when bills are received or Indemnified Damages are incurred.

 

(e) The
indemnity agreements contained herein shall be in addition to (i) any cause of action or similar right of the Indemnified Party or
Indemnified Person against the indemnifying party or others, and (ii) any liabilities the indemnifying party may be subject to pursuant
to the law.

 

7. CONTRIBUTION.

 

To the extent any indemnification
by an indemnifying party is prohibited or limited by law, the indemnifying party agrees to make the maximum contribution with respect
to any amounts for which it would otherwise be liable under Section 6 to the fullest extent permitted by law; provided, however, that:
(i) no seller of Registrable Securities guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities
Act) shall be entitled to contribution from any seller of Registrable Securities who was not guilty of fraudulent misrepresentation; and
(ii) contribution by any seller of Registrable Securities shall be limited in amount to the net amount of proceeds received by such seller
from the sale of such Registrable Securities.

 

8. REPORTS
UNDER THE EXCHANGE ACT.

 

With a view to making available
to the Investors the benefits of Rule 144 promulgated under the Securities Act or any similar rule or regulation of the SEC that may at
any time permit the Investors to sell securities of the Company to the public without registration, and as a material inducement to the
Investor’s purchase of the Newly Issued Shares, the Company represents, warrants, and covenants to the following:

 

(a) The
Company is subject to the reporting requirements of section 13 or 15(d) of the Exchange Act and has filed all required reports under section
13 or 15(d) of the Exchange Act during the 12 months prior to the date hereof (or for such shorter period that the issuer was required
to file such reports), other than Form 8-K reports.

 

    A-8

     

    

 

(b) During
the Registration Period, the Company shall file with the SEC in a timely manner all required reports under section 13 or 15(d) of the
Exchange Act and such reports shall conform to the requirement of the Exchange Act and the SEC for filing thereunder.

 

(c) The
Company shall furnish to the Investor so long as such Investor owns Registrable Securities, promptly upon request, (i) a written statement
by the Company that it has complied with the reporting requirements of Rule 144, (ii) a copy of the most recent annual or quarterly report
of the Company and such other reports and documents so filed by the Company, and (iii) such other information as may be reasonably requested
to permit the Investors to sell such securities pursuant to Rule 144 without registration.

 

9. RESERVED.

 

10. MISCELLANEOUS.

 

(a) Any
notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement must be in writing
and will be deemed to have been delivered pursuant to the notice provisions of the Letter Agreement or to such other address and/or electronic
mail address and/or to the attention of such other person as the recipient party has specified by written notice given to each other party
five (5) days prior to the effectiveness of such change. Written confirmation of receipt (A) given by the recipient of such notice, consent,
waiver or other communication, (B) electronically generated by the sender’s email service provider containing the time, date, and
recipient email or (C) provided by a courier or overnight courier service shall be rebuttable evidence of personal service, receipt by
facsimile or receipt from a nationally recognized overnight delivery service in accordance with this section.

 

(b) Failure
of any party to exercise any right or remedy under this Agreement or otherwise, or delay by a party in exercising such right or remedy,
shall not operate as a waiver thereof.

 

(c) The
laws of the State of New York shall govern all issues concerning the relative rights of the Company and the Investors as its stockholders.
All other questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by the internal
laws of the State of New York, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of
New York or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of New York.
Each party hereby irrevocably submits to the non-exclusive jurisdiction of the Supreme Court of the State of New York, sitting in New
York County, New York and federal courts for the Southern District of New York sitting New York, New York, for the adjudication of any
dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives,
and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such
court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is
improper. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action
or proceeding by mailing a copy thereof to such party at the address for such notices to it under this Agreement and agrees that such
service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit
in any way any right to serve process in any manner permitted by law. If any provision of this Agreement shall be invalid or unenforceable
in any jurisdiction, such invalidity or unenforceability shall not affect the validity or enforceability of the remainder of this Agreement
in that jurisdiction or the validity or enforceability of any provision of this Agreement in any other jurisdiction. EACH PARTY HEREBY
IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN
CONNECTION HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.

 

    A-9

     

    

 

(d) This
Agreement shall inure to the benefit of and be binding upon the permitted successors and assigns of each of the parties hereto.

 

(e) The
headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof.

 

(f) This
Agreement may be executed in identical counterparts, each of which shall be deemed an original but all of which shall constitute one and
the same agreement. This Agreement, once executed by a party, may be delivered to the other party hereto as an attachment to an email
of a copy of this Agreement bearing the signature of the party so delivering this Agreement.

 

(g) Each
party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such
other agreements, certificates, instruments and documents, as the other party may reasonably request in order to carry out the intent
and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.

 

(h) The
language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent and no rules of
strict construction will be applied against any party.

 

(i) This
Agreement is intended for the benefit of the parties hereto and their respective permitted successors and assigns, and is not for the
benefit of, nor may any provision hereof be enforced by, any other Person.

 

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

 

    A-10

     

    

 

IN WITNESS WHEREOF,
the Investor and the Company have caused their signature page to this Registration Rights Agreement to be duly executed as of the date
first above written.

 

	 	COMPANY:
	 	GREENROSE ACQUISITION CORP., INC.
	 	 	 
	 	By:	                       
	 	Name:	 
	 	Title:	 
	 	 	 
	 	INVESTOR:
	 	YA II PN, Ltd.
	 	 	 
	 	By: Yorkville Advisors Global, LP
	 	Its:  Investment Manager
	 	 	 
	 	 	By:	Yorkville Advisors Global II, LLC
	 	 	Its:	General Partner
	 	 	 
	 	 	By:	            
	 	 	Name:	 
	 	 	Title:	 

 

    A-11

     

    

 

EXHIBIT B

 

STANDBY EQUITY PURCHASE AGREEMENT

 

THIS STANDBY EQUITY PURCHASE
AGREEMENT (this “Agreement”) dated as of October ___, 2021 is made by and between YA II PN, LTD., a Cayman
Islands exempt limited partnership (the “Investor”), and GREENROSE ACQUISITION CORP. a company incorporated
under the laws of the State of Delaware (the “Company”).

 

WHEREAS, the parties
desire that, upon the terms and subject to the conditions contained herein, the Company shall have the right to issue and sell to the
Investor, from time to time as provided herein, and the Investor shall purchase from the Company, up to $100 million of the Company’s
shares of common stock, par value $0.0001 per share (the “Common Shares”); and

 

WHEREAS, the Common
Shares are listed for trading on the OTCQX tier of the OTC Market Group under the symbol “GNRS;” and

 

WHEREAS, the offer
and sale of the Common Shares issuable hereunder will be made in reliance upon Section 4(a)(2) under the Securities Act of 1933, as amended,
and the rules and regulations promulgated thereunder (the “Securities Act”), or upon such other exemption from the
registration requirements of the Securities Act as may be available with respect to any or all of the transactions to be made hereunder.

 

NOW, THEREFORE,
the parties hereto agree as follows:

 

Article I. Certain Definitions

 

Section 1.01
“Additional Shares” shall have the meaning set forth in Section 2.01(d)(ii).

 

Section 1.02
“Adjusted Advance Amount” shall have the meaning set forth in Section 2.01(d)(i).

 

Section 1.03
“Advance Date” shall mean the 1st Trading Day after expiration of the applicable Pricing Period for
each Advance.

 

Section 1.04
“Advance Notice” shall mean a written notice in the form of Exhibit A attached hereto to the Investor executed
by an officer of the Company and setting forth the amount of an Advance that the Company desires to issue and sell to the Investor.

 

Section 1.05
“Advance Notice Date” shall mean each date the Company delivers (in accordance with Section 2.01(b) of this
Agreement) to the Investor an Advance Notice, subject to the terms of this Agreement.

 

Section 1.06
“Advances” shall mean any issuance and sale from the Company to the Investor pursuant to Article II hereof.

 

Section 1.07
“Affiliate” shall have the meaning set forth in Section 3.07.

 

Section 1.08
“Agreement” shall have the meaning set forth in the preamble of this Agreement.

 

    B-1

     

    

 

Section 1.09
“Applicable Laws” shall mean all applicable laws, statutes, rules, regulations, orders, executive orders, directives,
policies, guidelines and codes having the force of law, whether local, national, or international, as amended from time to time, including
without limitation (i) all applicable laws that relate to money laundering, terrorist financing, financial record keeping and reporting,
(ii) all applicable laws that relate to anti-bribery, anti-corruption, books and records and internal controls, including the United States
Foreign Corrupt Practices Act of 1977, and (iii) any Sanctions laws.

 

Section 1.10
“Basket” shall have the meaning set forth in Section 5.04.

 

Section 1.11
“Black Out Period” shall have the meaning set forth in Section 6.02

 

Section 1.12
“Closing” shall have meaning set forth in Section 2.02.

 

Section 1.13
“Commitment Amount” shall mean $100,000,000 of Common Shares.

 

Section 1.14
“Commitment Fee Shares” shall have the meaning set forth in Section 13.04.

 

Section 1.15
“Commitment Period” shall mean the period commencing on the date of closing of the Qualified Business Combination
(as defined (as defined in the Definitive Proxy Statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on October
5, 2021) hereof and expiring upon the date of termination of this Agreement in accordance with Section 11.02.

 

Section 1.16
“Common Shares” shall have the meaning set forth in the recitals of this Agreement.

 

Section 1.17
“Company” shall have the meaning set forth in the preamble of this Agreement.

 

Section 1.18
“Company Indemnitees” shall have the meaning set forth in Section 5.02.

 

Section 1.19
“Condition Satisfaction Date” shall have the meaning set forth in Section 7.01.

 

Section 1.20
“Daily Value Traded” shall mean the product obtained by multiplying the daily trading volume of the Company’s
Common Shares on the Principal Market during regular trading hours as reported by Bloomberg L.P., by the VWAP for such Trading Day.

 

Section 1.21
“Environmental Laws” shall have the meaning set forth in Section 4.08.

 

Section 1.22
“Exchange Act” shall mean the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated
thereunder.

 

Section 1.23
“Excluded Day” shall have the meaning set forth in Section 2.01(d)(i).

 

Section 1.24
“Hazardous Materials” shall have the meaning set forth in Section 4.08.

 

Section 1.25
“Indemnified Liabilities” shall have the meaning set forth in Section 5.01.

 

    B-2

     

    

 

Section 1.26
“Investor” shall have the meaning set forth in the preamble of this Agreement.

 

Section 1.27
“Investor Indemnitees” shall have the meaning set forth in Section 5.01.

 

Section 1.28
“Market Price” shall mean the lowest daily VWAP of the Common Shares during the relevant Pricing Period, other
than the daily VWAP on any Excluded Days.

 

Section 1.29
“Material Adverse Effect” shall mean any event, occurrence or condition that has had or would reasonably be
expected to have (i) a material adverse effect on the legality, validity or enforceability of this Agreement or the transactions contemplated
herein, (ii) a material adverse effect on the results of operations, assets, business or condition (financial or otherwise) of the Company
and its Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company’s ability to perform in any material respect
on a timely basis its obligations under this Agreement.

 

Section 1.30
“Material Outside Event” shall have the meaning set forth in Section 6.08.

 

Section 1.31
“Maximum Advance Amount” in respect of each Advance Notice means the greater of: (i) $2,000,000, or (ii) an
amount equal to 20% of the sum of the Daily Value Traded of Common Shares on the Company’s Principal Market on each Trading Day
during the period of 5 consecutive Trading Days ending on the last completed full Trading Day immediately preceding the time the Company
delivers each Advance Notice Date.

 

Section 1.32
“Minimum Acceptable Price” or “MAP” shall mean the minimum price notified by the Company
to the Investor in each Advance Notice, if applicable.

 

Section 1.33
“OFAC” shall mean the U.S. Department of Treasury’s Office of Foreign Asset Control.

 

Section 1.34
“Ownership Limitation” shall have the meaning set forth in Section 2.01(c)(i).

 

Section 1.35
“Person” shall mean an individual, a corporation, a partnership, a limited liability company, a trust or other
entity or organization, including a government or political subdivision or an agency or instrumentality thereof.

 

Section 1.36
“Plan of Distribution” shall mean the section of a Registration Statement disclosing the plan of distribution
of the Shares.

 

Section 1.37
“Pricing Period” shall mean the three (3) consecutive Trading Days commencing on the Advance Notice Date.

 

Section 1.38
“Principal Market” shall mean the New York Stock Exchange, the Nasdaq Global Select Market, the Nasdaq Global
Market, the Nasdaq Capital Market, the OTCQX, OTCQB, or the NYSE Euronext, whichever is at the time the principal trading exchange or
market for the Common Shares.

 

Section 1.39
“Prospectus” means any prospectus (including, without limitation, all amendments and supplements thereto) used
in connection with a Registration Statement.

 

    B-3

     

    

 

Section 1.40
“Prospectus Supplement” shall mean any prospectus supplement to a Prospectus filed with the SEC pursuant to
Rule 424(b) under the Securities Act, including, without limitation, any Prospectus Supplement to be filed in accordance with Section
6.01 hereof.

 

Section 1.41
“Purchase Price” shall mean the price per Share obtained by multiplying the Market Price by 96%.

 

Section 1.42
“Registrable Securities” shall mean (i) the Shares, and (ii) any securities issued or issuable with respect
to any of the foregoing by way of exchange, stock dividend or stock split or in connection with a combination of shares, recapitalization,
merger, consolidation or other reorganization or otherwise.

 

Section 1.43
“Registration Limitation” shall have the meaning set forth in Section 2.01(c)(ii).

 

Section 1.44
“Registration Statement” shall mean a registration statement on Form S-1 or Form S-3 or on such other form promulgated
by the SEC for which the Company then qualifies and which counsel for the Company shall deem appropriate, and which form shall be available
for the registration of the resale by the Investor of the Registrable Securities under the Securities Act.

 

Section 1.45
“Regulation D” shall mean the provisions of Regulation D promulgated under the Securities Act.

 

Section 1.46
“Sanctions” means any sanctions administered or enforced by OFAC, the U.S. State Department, the United Nations
Security Council, the European Union, Her Majesty’s Treasury, or other relevant sanctions authority.

 

Section 1.47
“Sanctions Programs” means any OFAC economic sanction program (including, without limitation, programs related
to Crimea, Cuba, Iran, North Korea, Sudan and Syria).

 

Section 1.48
“SEC” shall mean the U.S. Securities and Exchange Commission.

 

Section 1.49
“SEC Documents” shall have the meaning set forth in Section 4.04.

 

Section 1.50
“Securities Act” shall have the meaning set forth in the recitals of this Agreement.

 

Section 1.51
“Settlement Document” shall have the meaning set forth in Section 2.02(a).

 

Section 1.52
“Shares” shall mean the Commitment Shares and the Common Shares to be issued from time to time hereunder pursuant
to an Advance.

 

Section 1.53
“Subsidiaries” shall have the meaning set forth in Section 4.01.

 

Section 1.54
“Trading Day” shall mean any day during which the Principal Market shall be open for business.

 

Section 1.55
“Transaction Documents” shall have the meaning set forth in Section 4.02.

 

Section 1.56
“VWAP” means, for any Trading Day, the daily volume weighted average price of the Common Shares for such Trading
Day on the Principal Market during regular trading hours as reported by Bloomberg L.P.

 

    B-4

     

    

 

Article II. Advances

 

Section 2.01
Advances; Mechanics. Subject to the terms and conditions of this Agreement (including, without limitation, the provisions
of Article VII hereof), the Company, at its sole and exclusive option, may issue and sell to the Investor, and the Investor shall purchase
from the Company, Common Shares on the following terms:

 

		(a)	Advance Notice. At any time during the Commitment Period the Company may require the Investor to
purchase Shares by delivering an Advance Notice to the Investor, subject to the conditions set forth in Section 7.01, and in accordance
with the following provisions:

 

		(i)	The Company shall, in its sole discretion, select the amount of the Advance, not to exceed the Maximum
Advance Amount, it desires to issue and sell to the Investor in each Advance Notice and the time it desires to deliver each Advance Notice.

 

		(ii)	There shall be no mandatory minimum Advances and no non-usages fee for not utilizing the Commitment Amount
or any part thereof.

 

		(b)	Date of Delivery of Advance Notice. Advance Notices shall be delivered in accordance with the instructions
set forth on the bottom of Exhibit A. An Advance Notice shall be deemed delivered on (i) the day it is received by the Investor
if such notice is received by email on or before 8:30 a.m. Eastern Time (or later if waived by the Investor in its sole discretion) in
accordance with the instructions set forth on the bottom of Exhibit A, or (ii) the immediately succeeding day if it is received by email
after 8:30 a.m. Eastern Time, in each case in accordance with the instructions set forth on the bottom of Exhibit A.

 

		(c)	Advance Limitations. Regardless of the amount of an Advance requested by the Company in the Advance
Notice, the final number of Shares to be issued and sold pursuant to an Advance Notice shall be reduced in accordance with each of the
following limitations:

 

		(i)	Ownership Limitation; Commitment Amount. In no event shall the number of Common Shares issuable
to the Investor pursuant to an Advance cause the aggregate number of Common Shares beneficially owned (as calculated pursuant to Section
13(d) of the Exchange Act) by the Investor and its Affiliates as a result of previous issuances and sales of Common Shares to Investor
under this Agreement to exceed 4.99% of the then outstanding Common Shares (the “Ownership Limitation”). In connection
with each Advance Notice delivered by the Company, any portion of the Advance that would (i) cause the Investor to exceed the Ownership
Limitation or (ii) cause the aggregate number of Shares issued and sold to the Investor hereunder to exceed the Commitment Amount shall
automatically be withdrawn with no further action required by the Company, and such Advance Notice shall be deemed automatically modified
to reduce the amount of the Advance requested by an amount equal to such withdrawn portion; provided that in the event of any such automatic
withdrawal and automatic modification, Investor will promptly notify the Company of such event.

 

    B-5

     

    

 

		(ii)	Registration Limitation. In no event shall an Advance exceed the amount registered under the Registration
Statement then in effect (the “Registration Limitation”) or the Exchange Cap, to the extent applicable. In connection
with each Advance Notice, any portion of an Advance that would exceed the Registration Limitation or the Exchange Cap shall automatically
be withdrawn with no further action required by the Company and such Advance Notice shall be deemed automatically modified to reduce the
aggregate amount of the requested Advance by an amount equal to such withdrawn portion in respect of each Advance Notice; provided that
in the event of any such automatic withdrawal and automatic modification, Investor will promptly notify the Company of such event.

 

		(d)	Minimum Acceptable Price, Excluded Days.

 

		(i)	With respect to each Advance Notice, the Company may notify the Investor of the MAP with respect to such
Advance by indicating a MAP on such Advance Notice. If no MAP is specified in an Advance Notice, then no MAP shall be in effect in connection
with such Advance. Each Trading Day during a Pricing Period for which (A) with respect to each Advance Notice with a MAP, the VWAP of
the Common Shares is below the Minimum Acceptable Price in effect with respect to such Advance Notice, or (B) there is no VWAP (each such
day, an “Excluded Day”), shall result in an automatic reduction to the amount of the Advance set forth in such Advance
Notice by one third (the resulting amount of each Advance being the “Adjusted Advance Amount”), and each Excluded Day
shall be excluded from the Pricing Period for purposes of determining the Market Price.

 

		(ii)	The total Shares in respect of each Advance (after reductions have been made to arrive at the Adjusted
Advance Amount) shall be automatically increased by such number of Common Shares (the “Additional Shares”) equal to
the number of Common Shares sold by the Investor on such Excluded Day, if any, and the price paid per share for each Additional Share
shall be equal to the MAP in effect with respect to such Advance Notice (without any further discount), provided that this increase shall
not cause the total Advance Shares to exceed the amount set forth in the original Advance Notice or any limitations set forth in Section
2.01(c).

 

		(e)	Notwithstanding any other provision in this Agreement, the Company and the Investor acknowledge and agree
that upon the Investor’s receipt of a valid Advance Notice the parties shall be deemed to have entered into an unconditional contract
binding on both parties for the purchase and sale of Shares pursuant to such Advance Notice in accordance with the terms of this Agreement
and (i) subject to Applicable Law and (ii) subject to Section 3.08 (Trading Activities), the Investor may sell Common Shares during
the Pricing Period.

 

    B-6

     

    

 

Section 2.02
Closings. The closing of each Advance and each sale and purchase of Shares (each, a “Closing”) shall
take place as soon as practicable on or after each Advance Date in accordance with the procedures set forth below. The parties acknowledge
that the Purchase Price is not known at the time the Advance Notice is delivered (at which time the Investor is irrevocably bound) but
shall be determined on each Closing based on the daily prices of the Common Shares that are the inputs to the determination of the Purchase
Price as set forth further below. In connection with each Closing, the Company and the Investor shall fulfill each of its obligations
as set forth below:

 

		(a)	On each Advance Date, the Investor shall deliver to the Company a written document, in the form attached
hereto as Exhibit B (each a “Settlement Document”), setting forth the final number of Shares to be purchased by the
Investor (taking into account any adjustments pursuant to Section 2.01), the Market Price, the Purchase Price, the aggregate proceeds
to be paid by the Investor to the Company, and a report by Bloomberg, L.P. indicating the VWAP for each of the Trading Days during the
Pricing Period (or, if not reported on Bloomberg, L.P., another reporting service reasonably agreed to by the parties), in each case in
accordance with the terms and conditions of this Agreement. The final number of Shares to be purchased by the Investor at the Closing
for such Advance shall equal the sum of (i) the Adjusted Advance Amount which shall be purchased at the Purchase Price plus (ii) the aggregate
number of Additional Shares elected to be purchased by the Investor on Excluded Days during such Pricing Period (as contemplated by Section
2.01(d)(ii)) which shall be purchased at the applicable MAP.

 

		(b)	Promptly after receipt of the Settlement Document with respect to each Advance (and, in any event, not
later than one Trading Day after such receipt), the Company will, or will cause its transfer agent to, electronically transfer such number
of Shares to be purchased by the Investor (as set forth in the Settlement Document) by crediting the Investor’s account or its designee’s
account at the Depository Trust Company through its Deposit Withdrawal at Custodian System or by such other means of delivery as may be
mutually agreed upon by the parties hereto, and transmit notification to the Investor that such share transfer has been requested. Promptly
upon receipt of such notification, the Investor shall pay to the Company the aggregate purchase price of the Shares (as set forth in the
Closing Statement) in cash in immediately available funds to an account designated by the Company in writing and transmit notification
to the Company that such funds transfer has been requested. No fractional shares shall be issued, and any fractional amounts shall be
rounded to the next higher whole number of shares. To facilitate the transfer of the Common Shares by the Investor, the Common Shares
will not bear any restrictive legends so long as there is an effective Registration Statement covering such Common Shares (it being understood
and agreed by the Investor that notwithstanding the lack of restrictive legends, the Investor may only sell such Common Shares pursuant
to the plan of distribution set forth in the Prospectus included in the Registration Statement and otherwise in compliance with the requirements
of the Securities Act (including any applicable prospectus delivery requirements) or pursuant to an available exemption).

 

    B-7

     

    

 

		(c)	On or prior to the Advance Date, each of the Company and the Investor shall deliver to the other all documents,
instruments and writings expressly required to be delivered by either of them pursuant to this Agreement in order to implement and effect
the transactions contemplated herein.

 

		(d)	Notwithstanding anything to the contrary in this Agreement, if on any day during the Pricing Period (i)
the Company notifies Investor that a Material Outside Event has occurred, or (ii) the Company notifies the Investor of a Black Out Period,
the parties agree that the pending Advance shall end and the final number of Shares to be purchased by the Investor at the Closing for
such Advance shall be equal to the number of Common Shares sold by the Investor during the applicable Pricing Period prior to the notification
from the Company of a Material Outside Event or Black Out Period.

 

Section 2.03
Hardship.

 

		(a)	In the event the Investor sells Common Shares after receipt of an Advance Notice and the Company fails
to perform its obligations as mandated in Section 2.02, the Company agrees that in addition to and in no way limiting the rights and obligations
set forth in Article V hereto and in addition to any other remedy to which the Investor is entitled at law or in equity, including, without
limitation, specific performance, it will hold the Investor harmless against any loss, claim, damage, or expense (including reasonable
legal fees and expenses), as incurred, arising out of or in connection with such default by the Company and acknowledges that irreparable
damage may occur in the event of any such default. It is accordingly agreed that the Investor shall be entitled to an injunction or injunctions
to prevent such breaches of this Agreement and to specifically enforce (subject to the Securities Act and other rules of the Principal
Market), without the posting of a bond or other security, the terms and provisions of this Agreement.

 

Section 2.04
Completion of Resale Pursuant to the Registration Statement. After the Investor has purchased the full Commitment Amount
and has completed the subsequent resale of the full Commitment Amount pursuant to the Registration Statement, Investor will notify the
Company that all subsequent resales are completed and the Company will be under no further obligation to maintain the effectiveness of
the Registration Statement.

 

Article III. Representations
and Warranties of Investor

 

Investor hereby represents
and warrants to, and agrees with, the Company that the following are true and correct as of the date hereof and as of each Advance Notice
Date and each Advance Date:

 

Section 3.01
Organization and Authorization. The Investor is duly organized, validly existing and in good standing under the laws of
the Cayman Islands and has all requisite power and authority to execute, deliver and perform this Agreement, including all transactions
contemplated hereby. The decision to invest and the execution and delivery of this Agreement by the Investor, the performance by the Investor
of its obligations hereunder and the consummation by the Investor of the transactions contemplated hereby have been duly authorized and
require no other proceedings on the part of the Investor. The undersigned has the right, power and authority to execute and deliver this
Agreement and all other instruments on behalf of the Investor or its shareholders. This Agreement has been duly executed and delivered
by the Investor and, assuming the execution and delivery hereof and acceptance thereof by the Company, will constitute the legal, valid
and binding obligations of the Investor, enforceable against the Investor in accordance with its terms.

 

    B-8

     

    

 

Section 3.02
Evaluation of Risks. The Investor has such knowledge and experience in financial, tax and business matters as to be capable
of evaluating the merits and risks of, and bearing the economic risks entailed by, an investment in the Common Shares of the Company and
of protecting its interests in connection with the transactions contemplated hereby. The Investor acknowledges and agrees that its investment
in the Company involves a high degree of risk, and that the Investor may lose all or a part of its investment.

 

Section 3.03
No Legal, Investment or Tax Advice from the Company. The Investor acknowledges that it had the opportunity to review this
Agreement and the transactions contemplated by this Agreement with its own legal counsel and investment and tax advisors. The Investor
is relying solely on such counsel and advisors and not on any statements or representations of the Company or any of the Company’s
representatives or agents for legal, tax, investment or other advice with respect to the Investor’s acquisition of Common Shares
hereunder, the transactions contemplated by this Agreement or the laws of any jurisdiction, and the Investor acknowledges that the Investor
may lose all or a part of its investment.

 

Section 3.04
Investment Purpose. The Investor is acquiring the Common Shares for its own account, for investment purposes and not with
a view towards, or for resale in connection with, the public sale or distribution thereof, except pursuant to sales registered under or
exempt from the registration requirements of the Securities Act; provided, however, that by making the representations herein,
the Investor does not agree, or make any representation or warranty, to hold any of the Securities for any minimum or other specific term
and reserves the right to dispose of the Securities at any time in accordance with, or pursuant to, a registration statement filed pursuant
to this Agreement or an applicable exemption under the Securities Act. The Investor does not presently have any agreement or understanding,
directly or indirectly, with any Person to sell or distribute any of the Common Shares. The Investor
acknowledges that it will be disclosed as an “underwriter” and a “selling stockholder” in each Registration Statement
and in any Prospectus contained therein.

 

Section 3.05
Accredited Investor. The Investor is an “Accredited Investor” as that term is defined in Rule 501(a)(3)
of Regulation D.

 

Section 3.06
Information. The Investor and its advisors (and its counsel), if any, have been furnished with all materials relating to
the business, finances and operations of the Company and information the Investor deemed material to making an informed investment decision.
The Investor and its advisors (and its counsel), if any, have been afforded the opportunity to ask questions of the Company and its management
and have received answers to such questions. Neither such inquiries nor any other due diligence investigations conducted by such Investor
or its advisors (and its counsel), if any, or its representatives shall modify, amend or affect the Investor’s right to rely on
the Company’s representations and warranties contained in this Agreement. The Investor acknowledges and agrees that the Company
has not made to the Investor, and the Investor acknowledges and agrees it has not relied upon, any representations and warranties of the
Company, its employees or any third party other than the representations and warranties of the Company contained in this Agreement. The
Investor understands that its investment involves a high degree of risk. The Investor has sought such accounting, legal and tax advice,
as it has considered necessary to make an informed investment decision with respect to the transactions contemplated hereby.

 

    B-9

     

    

 

Section 3.07
Not an Affiliate. The Investor is not an officer, director or a person that directly, or indirectly through one or more
intermediaries, controls or is controlled by, or is under common control with the Company or any “affiliate” of the
Company (as that term is defined in Rule 405 promulgated under the Securities Act).

 

Section 3.08
Trading Activities. The Investor’s trading activities with respect to the Common Shares shall be in compliance with
all applicable federal and state securities laws, rules and regulations and the rules and regulations of the Principal Market. Neither
the Investor nor its affiliates has any open short position in the Common Shares, nor has the Investor entered into any hedging transaction
that establishes a net short position with respect to the Common Shares, and the Investor agrees that it shall not, and that it will cause
its affiliates not to, engage in any short sales or hedging transactions with respect to the Common Shares; provided that the Company
acknowledges and agrees that upon receipt of an Advance Notice the Investor has the right to sell (a) the Shares to be issued to the Investor
pursuant to the Advance Notice prior to receiving such Shares, or (b) other Common Shares sold by the Company to Investor pursuant to
this Agreement and which the Company has continuously held as a long position.

 

Section 3.09
General Solicitation. Neither the Investor, nor any of its affiliates, nor any person acting on its or their behalf, has
engaged or will engage in any form of general solicitation or general advertising (within the meaning of Regulation D) in connection with
any offer or sale of the Common Shares by the Investor.

 

Article IV. Representations
and Warranties of the Company

 

Except as set forth in the
SEC Documents, or in the Disclosure Schedules, which Disclosure Schedules shall be deemed a part hereof and shall qualify any representation
or warranty otherwise made herein to the extent of the disclosure contained in the corresponding section of the Disclosure Schedules or
in another Section of the Disclosure Schedules, to the extent that it is reasonably apparent on the face of such disclosure that such
disclosure is applicable to such Section, the Company represents and warrants to the Investor that, as of the date hereof, each Advance
Notice Date and each Advance Date (other than representations and warranties which address matters only as of a certain date, which shall
be true and correct as written as of such certain date), that:

 

    B-10

     

    

 

Section 4.01
Organization and Qualification. Each of the Company and its Subsidiaries (as defined below) is an entity duly organized
and validly existing under the laws of its state of organization or incorporation, and has the requisite power and authority to own its
properties and to carry on its business as now being conducted. Each of the Company and its Subsidiaries is duly qualified to do business
and is in good standing (to the extent applicable) in every jurisdiction in which the nature of the business conducted by it makes such
qualification necessary, except to the extent that the failure to be so qualified or be in good standing would not have a Material Adverse
Effect. “Subsidiaries” means any Person (as defined below) in which the Company, directly or indirectly, (x) owns any
of the outstanding capital stock or holds any equity or similar interest of such Person or (y) controls or operates all or any part of
the business, operations or administration of such Person, and each of the foregoing, is individually referred to herein as a “Subsidiary.”

 

Section 4.02
Authorization, Enforcement, Compliance with Other Instruments. The Company has the requisite corporate power and authority
to enter into and perform its obligations under this Agreement and the other Transaction Documents and to issue the Shares in accordance
with the terms hereof and thereof. The execution and delivery by the Company of this Agreement and the other Transaction Documents, and
the consummation by the Company of the transactions contemplated hereby and thereby (including, without limitation, the issuance of the
Common Shares) have been or (with respect to consummation) will be duly authorized by the Company’s board of directors and no further
consent or authorization will be required by the Company, its board of directors or its shareholders. This Agreement and the other Transaction
Documents to which it is a party have been (or, when executed and delivered, will be) duly executed and delivered by the Company and,
assuming the execution and delivery thereof and acceptance by the Investor, constitute (or, when duly executed and delivered, will be)
the legal, valid and binding obligations of the Company, enforceable against the Company in accordance with their respective terms, except
as such enforceability may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium,
liquidation or other laws relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies and
except as rights to indemnification and to contribution may be limited by federal or state securities law. “Transaction Documents”
means, collectively, this Agreement and each of the other agreements and instruments entered into or delivered by any of the parties hereto
in connection with the transactions contemplated hereby and thereby, as may be amended from time to time.

 

Section 4.03
Authorization of the Shares. The Shares to be issued under this Agreement have been, or with respect to Shares to be purchased
by the Investor pursuant to an Advance Notice, will be, when issued and delivered pursuant to the terms approved by the board of directors
of the Company or a duly authorized committee thereof, or a duly authorized executive committee, against payment therefor as provided
herein, duly and validly authorized and issued and fully paid and nonassessable, free and clear of any pledge, lien, encumbrance, security
interest or other claim, including any statutory or contractual preemptive rights, resale rights, rights of first refusal or other similar
rights, and will be registered pursuant to Section 12 of the Exchange Act. The Shares, when issued, will conform to the description thereof
set forth in or incorporated into the Prospectus.

 

    B-11

     

    

 

Section 4.04
No Conflict. The execution, delivery and performance of the Transaction Documents by the Company and the consummation by
the Company of the transactions contemplated hereby and thereby (including, without limitation, the issuance of the Common Shares) will
not (i) result in a violation of the articles of incorporation or other organizational documents of the Company or its Subsidiaries (with
respect to consummation, as the same may be amended prior to the date on which any of the transactions contemplated hereby are consummated),
(ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or
give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument to which
the Company or its Subsidiaries is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including
federal and state securities laws and regulations) applicable to the Company or its Subsidiaries or by which any property or asset of
the Company or its Subsidiaries is bound or affected except, in the case of clause (ii) or (iii) above, to the extent such violations
that would not reasonably be expected to have a Material Adverse Effect.

 

Section 4.05
SEC Documents; Financial Statements. The Company has filed all reports, schedules, forms, statements and other documents
required to be filed by it with the SEC pursuant to the Exchange Act for the two years preceding the date hereof (or such shorter period
as the Company was required by law or regulation to file such material) (all of the foregoing filed within two years preceding the date
hereof or amended after the date hereof, or filed after the date hereof, and all exhibits included therein and financial statements and
schedules thereto and documents incorporated by reference therein, and all registration statements filed by the Company under the Securities
Act, being hereinafter referred to as the “SEC Documents”). The Company has made available to the Investor through
the SEC’s website at http://www.sec.gov, true and complete copies of the SEC Documents.

 

Section 4.06
Financial Statements. The consolidated financial statements of the Company included or incorporated by reference in SEC
Documents, together with the related notes and schedules, present fairly, in all material respects, the consolidated financial position
of the Company and the Subsidiaries as of the dates indicated and the consolidated results of operations, cash flows and changes in stockholders’
equity of the Company for the periods specified and have been prepared in compliance with the requirements of the Securities Act and Exchange
Act and in conformity with generally accepted accounting principles in the United States (“GAAP”) applied on a consistent
basis (except for (i) such adjustments to accounting standards and practices as are noted therein, (ii) in the case of unaudited interim
financial statements, to the extent such financial statements may not include footnotes required by GAAP or may be condensed or summary
statements and (iii) such adjustments which will not be material, either individually or in the aggregate) during the periods involved;
the other financial and statistical data with respect to the Company and the Subsidiaries (as defined below) contained or incorporated
by reference in the SEC Documents are accurately and fairly presented and prepared on a basis consistent with the financial statements
and books and records of the Company; there are no financial statements (historical or pro forma) that are required to be included or
incorporated by reference in the SEC Documents that are not included or incorporated by reference as required; the Company and the Subsidiaries
(as defined below) do not have any material liabilities or obligations, direct or contingent (including any off-balance sheet obligations),
not described in the SEC Documents (excluding the exhibits thereto); and all disclosures contained or incorporated by reference in the
SEC Documents regarding “non-GAAP financial measures” (as such term is defined by the rules and regulations of the Commission)
comply in all material respects with Regulation G of the Exchange Act and Item 10 of Regulation S-K under the Securities Act, to the extent
applicable. The interactive data in eXtensible Business Reporting Language included or incorporated by reference in the SEC Documents
fairly presents the information called for in all material respects and has been prepared in accordance with the SEC’s rules and
guidelines applicable thereto.

 

    B-12

     

    

 

Section 4.07
Registration Statement and Prospectus. The Company and the transactions contemplated by this Agreement meet the requirements
for and comply with the conditions for the use of Form S-1 under the Securities Act. Each Registration Statement and the offer and sale
of Shares as contemplated hereby meet the requirements of Rule 415 under the Securities Act and comply in all material respects with
said Rule. Any statutes, regulations, contracts or other documents that are required to be described in a Registration Statement or a
Prospectus, or to be filed as exhibits to a Registration Statement have been so described or filed. Copies of each Registration Statement,
any Prospectus, and any such amendments or supplements and all documents incorporated by reference therein that were filed with the Commission
on or prior to the date of this Agreement have been delivered, or are available through EDGAR, to the Investor and its counsel. The Company
has not distributed and, prior to the later to occur of each Settlement Date and completion of the distribution of the Shares, will not
distribute any offering material in connection with the offering or sale of the Shares other than a Registration Statement and the Prospectus
and any Issuer Free Writing Prospectus (as defined below) to which the Investor has consented.

 

Section 4.08
No Misstatement or Omission. Each Registration Statement, when it became or becomes effective, and any Prospectus, on the
date of such Prospectus or amendment or supplement, conformed and will conform in all material respects with the requirements of the Securities
Act. At each Advance Date, the Registration Statement, and the Prospectus, as of such date, will conform in all material respects with
the requirements of the Securities Act. Each Registration Statement, when it became or becomes effective, did not, and will not, contain
an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements
therein not misleading. Each Prospectus did not, or will not, include an untrue statement of a material fact or omit to state a material
fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading. The documents
incorporated by reference in a Prospectus or any Prospectus Supplement did not, and any further documents filed and incorporated by reference
therein will not, when filed with the Commission, contain an untrue statement of a material fact or omit to state a material fact required
to be stated in such document or necessary to make the statements in such document, in light of the circumstances under which they were
made, not misleading. The foregoing shall not apply to statements in, or omissions from, any such document made in reliance upon, and
in conformity with, information furnished to the Company by the Investor specifically for use in the preparation thereof.

 

Section 4.09
Conformity with Securities Act and Exchange Act. Each Registration Statement, each Prospectus, or any amendment or supplement
thereto, and the documents incorporated by reference in each Registration Statement, Prospectus or any amendment or supplement thereto,
when such documents were or are filed with the SEC under the Securities Act or the Exchange Act or became or become effective under the
Securities Act, as the case may be, conformed or will conform in all material respects with the requirements of the Securities Act and
the Exchange Act, as applicable.

 

    B-13

     

    

 

Section 4.10
Equity Capitalization. As of the date hereof, the authorized capital of the Company consists of 70,000,000 shares of common
stock and 1,000,000 shares of preferred stock. As od the date hereof, the Company had 5,682,154 shares of common stock outstanding and
no shares of preferred stock outstanding. The Common Shares are registered pursuant to Section 12(b) of the Exchange Act and is currently
listed on a Principal Market under the trading symbol “GNRS.” The Company has taken no action designed to, or likely to have
the effect of, terminating the registration of the Common Shares under the Exchange Act, delisting the Common Shares from the Principal
Market, nor has the Company received any notification that the Commission or the Principal Market is contemplating terminating such registration
or listing. To the Company’s knowledge, it is in compliance with all applicable listing requirements of the Principal Market.

 

Section 4.11
Intellectual Property Rights. The Company and its Subsidiaries own or possess adequate rights or licenses to use all material
trademarks, trade names, service marks, service mark registrations, service names, patents, patent rights, copyrights, inventions, licenses,
approvals, governmental authorizations, trade secrets and rights, if any, necessary to conduct their respective businesses as now conducted,
except as would not cause a Material Adverse Effect. The Company and its Subsidiaries have not received written notice of any infringement
by the Company or its Subsidiaries of trademark, trade name rights, patents, patent rights, copyrights, inventions, licenses, service
names, service marks, service mark registrations, or trade secrets, except as would not cause a Material Adverse Effect. To the knowledge
of the Company, there is no claim, action or proceeding being made or brought against, or to the Company’s knowledge, being threatened
against the Company or its Subsidiaries regarding trademark, trade name, patents, patent rights, invention, copyright, license, service
names, service marks, service mark registrations, trade secret or other infringement; and, except as would not cause a Material Adverse
Effect, the Company is not aware of any facts or circumstances which might give rise to any of the foregoing.

 

Section 4.12
Employee Relations. Neither the Company nor any of its Subsidiaries is involved in any labor dispute nor, to the knowledge
of the Company or any of its Subsidiaries, is any such dispute threatened, in each case which is reasonably likely to cause a Material
Adverse Effect.

 

Section 4.13
Environmental Laws. The Company and its Subsidiaries (i) have not received written notice alleging any failure to comply
in all material respects with all Environmental Laws (as defined below), (ii) have received all permits, licenses or other approvals required
of them under applicable Environmental Laws to conduct their respective businesses and (iii) have not received written notice alleging
any failure to comply with all terms and conditions of any such permit, license or approval where, in each of the foregoing clauses (i),
(ii) and (iii), the failure to so comply would be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.
The term “Environmental Laws” means all applicable federal, state and local laws relating to pollution or protection
of human health or the environment (including, without limitation, ambient air, surface water, groundwater, land surface or subsurface
strata), including, without limitation, laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants,
contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous Materials”) into the environment,
or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous
Materials, as well as all authorizations, codes, decrees, demands or demand letters, injunctions, judgments, licenses, notices or notice
letters, orders, permits, plans or regulations issued, entered, promulgated or approved thereunder.

 

    B-14

     

    

 

Section 4.14
Title. Except as would not cause a Material Adverse Effect, the Company (or its Subsidiaries) have indefeasible fee simple
or leasehold title to its properties and material assets owned by it, free and clear of any pledge, lien, security interest, encumbrance,
claim or equitable interest other than such as are not material to the business of the Company. Any real property and facilities held
under lease by the Company and its Subsidiaries are held by them under valid, subsisting and enforceable leases with such exceptions as
are not material and do not interfere with the use made and proposed to be made of such property and buildings by the Company and its
Subsidiaries.

 

Section 4.15
Insurance. The Company and each of its Subsidiaries are insured by insurers of recognized financial responsibility against
such losses and risks and in such amounts as management of the Company believes to be prudent and customary in the businesses in which
the Company and its Subsidiaries are engaged. The Company has no reason to believe that it will not be able to renew its existing insurance
coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business
at a cost that would not have a Material Adverse Effect.

 

Section 4.16
Regulatory Permits. Except as would not cause a Material Adverse Effect, the Company and its Subsidiaries possess all material
certificates, authorizations and permits issued by the appropriate federal, state or foreign regulatory authorities necessary to own their
respective businesses, and neither the Company nor any such Subsidiary has received any written notice of proceedings relating to the
revocation or modification of any such certificate, authorization or permits.

 

Section 4.17
Internal Accounting Controls. The Company maintains a system of internal accounting controls sufficient to provide reasonable
assurance that (i) transactions are executed in accordance with management’s general or specific authorizations, (ii) transactions
are recorded as necessary to permit preparation of financial statements in conformity with generally accepted accounting principles and
to maintain asset accountability, (iii) access to assets is permitted only in accordance with management’s general or specific authorization
and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is
taken with respect to any differences, and management is not aware of any material weaknesses that are not disclosed in the SEC Documents
as and when required.

 

Section 4.18
Absence of Litigation. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board,
government agency, self-regulatory organization or body pending against or affecting the Company, the Common Shares or any of the Company’s
Subsidiaries, wherein an unfavorable decision, ruling or finding would have a Material Adverse Effect.

 

    B-15

     

    

 

Section 4.19
Subsidiaries. The Company does not presently own or control, directly or indirectly, any interest in any other corporation,
partnership, association or other business entity.

 

Section 4.20
Tax Status. Each of the Company and its Subsidiaries (i) has timely made or filed all foreign, federal and state income
and all other tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has timely paid all taxes
and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and
declarations, except those being contested in good faith and (iii) has set aside on its books provision reasonably adequate for the payment
of all taxes for periods subsequent to the periods to which such returns, reports or declarations apply. The Company has not received
written notification any unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers
of the Company and its Subsidiaries know of no basis for any such claim where failure to pay would cause a Material Adverse Effect.

 

Section 4.21
Certain Transactions. Except as not required to be disclosed pursuant to Applicable Law, none of the officers or directors
of the Company is presently a party to any transaction with the Company (other than for services as employees, officers and directors),
including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real
or personal property to or from, or otherwise requiring payments to or from any officer or director, or to the knowledge of the Company,
any corporation, partnership, trust or other entity in which any officer or director has a substantial interest or is an officer, director,
trustee or partner.

 

Section 4.22
Rights of First Refusal. The Company is not obligated to offer the Common Shares offered hereunder on a right of first refusal
basis or otherwise to any third parties including, but not limited to, current or former shareholders of the Company, underwriters, brokers,
agents or other third parties.

 

Section 4.23
Dilution. The Company is aware and acknowledges that issuance of Common Shares hereunder could cause dilution to existing
shareholders and could significantly increase the outstanding number of Common Shares.

 

Section 4.24
Acknowledgment Regarding Investor’s Purchase of Shares. The Company acknowledges and agrees that the Investor is acting
solely in the capacity of an arm’s length investor with respect to this Agreement and the transactions contemplated hereunder. The
Company further acknowledges that the Investor is not acting as a financial advisor or fiduciary of the Company (or in any similar capacity)
with respect to this Agreement and the transactions contemplated hereunder and any advice given by the Investor or any of its representatives
or agents in connection with this Agreement and the transactions contemplated hereunder is merely incidental to the Investor’s purchase
of the Shares hereunder. The Company is aware and acknowledges that it shall not be able to request Advances under this Agreement if the
Registration Statement is not effective or if any issuances of Common Shares pursuant to any Advances would violate any rules of the Principal
Market. The Company acknowledged and agrees that it is capable of evaluating and understanding, and understands and accepts, the terms,
risks and conditions of the transactions contemplated by this Agreement.

 

    B-16

     

    

 

Section 4.25
Finder’s Fees. Neither the Company nor any of the Subsidiaries has incurred any liability for any finder’s fees,
brokerage commissions or similar payments in connection with the transactions herein contemplated. 

 

Section 4.26
Relationship of the Parties. Neither the Company, nor any of its subsidiaries, affiliates, nor any person acting on its
or their behalf is a client or customer of the Investor or any of its affiliates and neither the Investor nor any of its affiliates has
provided, or will provide, any services to the Company or any of its affiliates, its subsidiaries, or any person acting on its or their
behalf. The Investor’s relationship to Company is solely as investor as provided for in the Transaction Documents. 

 

Section 4.27
Operations. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with
and  neither the Company nor the Subsidiaries, nor any director, officer, or employee of the
Company or any Subsidiary nor, to the Company’s knowledge, any agent, affiliate or other person acting on behalf of the Company
or any Subsidiary has, not complied with Applicable Law; and no action, suit or proceeding by or before any governmental authority involving
the Company or any of its Subsidiaries with respect to Applicable Laws is pending or, to the knowledge of the Company, threatened.

 

Section 4.28
Forward-Looking Statements. No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section
21E of the Exchange Act) contained in the Registration Statement or a Prospectus has been made or reaffirmed without a reasonable basis
or has been disclosed other than in good faith.

 

Section 4.29
Compliance with Laws. The Company and each of its Subsidiaries are in compliance with Applicable Laws; the Company has not
received a notice of non-compliance, nor knows of, nor has reasonable grounds to know of, any facts that any director, officer, or employee
of the Company or any Subsidiary nor, to the Company’s knowledge, any agent, affiliate or other person acting on behalf of the Company
or any Subsidiary has, has not complied with Applicable Laws, or could give rise to a notice of non-compliance with Applicable Laws, and
is not aware of any pending change or contemplated change to any applicable law or regulation or governmental position; in each case that
would materially adversely affect the business of the Company or the business or legal environment under which the Company operates.

 

Section 4.30
Sanctions Matters. Neither the Company, nor any Subsidiary of the Company, nor, to the Company’s knowledge, any director,
officer, agent, employee or affiliate of the Company or any Subsidiary of the Company, is a Person that is, or is owned or controlled
by a Person that is:

 

		(a)	on the list of Specially Designated Nationals and Blocked Persons maintained by OFAC from time to time;

 

		(b)	the subject of any Sanctions; or

 

    B-17

     

    

 

		(c)	has a place of business in, or is operating, organized, resident or doing business in a country or territory
that is, or whose government is, the subject of Sanctions Programs (including without limitation Crimea, Cuba, Iran, North Korea, Sudan
and Syria).

 

Article V. Indemnification

 

The Investor and the Company
represent to the other the following with respect to itself:

 

Section 5.01
Indemnification by the Company. In consideration of the Investor’s execution and delivery of this Agreement, and in
addition to all of the Company’s other obligations under this Agreement, the Company shall defend, protect, indemnify and hold harmless
the Investor and its investment manager, Yorkville Advisors Global, LP, and each of their respective officers, directors, managers, members,
partners, employees and agents (including, without limitation, those retained in connection with the transactions contemplated by this
Agreement) and each person who controls the Investor within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange
Act (collectively, the “Investor Indemnitees”) from and against any and all actions, causes of action, suits, claims,
losses, costs, penalties, fees, liabilities and damages, and reasonable and documented expenses in connection therewith (irrespective
of whether any such Investor Indemnitee is a party to the action for which indemnification hereunder is sought), and including reasonable
attorneys’ fees and disbursements (the “Indemnified Liabilities”), incurred by the Investor Indemnitees or any
of them as a result of, or arising out of, or relating to (a) any untrue statement or alleged untrue statement of a material fact contained
in the Registration Statement for the registration of the Shares as originally filed or in any amendment thereof, or in any related prospectus,
or in any amendment thereof or supplement thereto, or arise out of or are based upon the omission or alleged omission to state therein
a material fact required to be stated therein or necessary to make the statements therein not misleading; provided, however,
that the Company will not be liable in any such case to the extent that any such loss, claim, damage or liability arises out of or is
based upon any such untrue statement or alleged untrue statement or omission or alleged omission made therein in reliance upon and in
conformity with written information furnished to the Company by or on behalf of the Investor specifically for inclusion therein; (b) any
material misrepresentation or breach of any material representation or material warranty made by the Company in this Agreement or any
other certificate, instrument or document contemplated hereby or thereby; or (c) any material breach of any material covenant, material
agreement or material obligation of the Company contained in this Agreement or any other certificate, instrument or document contemplated
hereby or thereby. To the extent that the foregoing undertaking by the Company may be unenforceable under Applicable Law, the Company
shall make the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities, which is permissible under
Applicable Law.

 

Section 5.02
Indemnification by the Investor. In consideration of the Company’s execution and delivery of this Agreement, and in
addition to all of the Investor’s other obligations under this Agreement, the Investor shall defend, protect, indemnify and hold
harmless the Company and all of its officers, directors, shareholders, employees and agents (including, without limitation, those retained
in connection with the transactions contemplated by this Agreement) and each person who controls the Investor within the meaning of Section
15 of the Securities Act or Section 20 of the Exchange Act (collectively, the “Company Indemnitees”) from and against
any and all Indemnified Liabilities incurred by the Company Indemnitees or any of them as a result of, or arising out of, or relating
to (a) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement for the registration
of the Shares as originally filed or in any amendment thereof, or in any related prospectus, or in any amendment thereof or supplement
thereto, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein
or necessary to make the statements therein not misleading; provided, however, that the Investor will only be liable for
written information relating to the Investor furnished to the Company by or on behalf of the Investor specifically for inclusion in the
documents referred to in the foregoing indemnity, and will not be liable in any such case to the extent that any such loss, claim, damage
or liability arises out of or is based upon any such untrue statement or alleged untrue statement or omission or alleged omission made
therein in reliance upon and in conformity with written information furnished to the Investor by or on behalf of the Company specifically
for inclusion therein; (b) any misrepresentation or breach of any representation or warranty made by the Investor in this Agreement or
any instrument or document contemplated hereby or thereby executed by the Investor; or (c) any breach of any covenant, agreement or obligation
of the Investor(s) contained in this Agreement or any other certificate, instrument or document contemplated hereby or thereby executed
by the Investor. To the extent that the foregoing undertaking by the Investor may be unenforceable under Applicable Law, the Investor
shall make the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities, which is permissible under
Applicable Law.

 

    B-18

     

    

 

Section 5.03
Notice of Claim. Promptly after receipt by an Investor Indemnitee or Company Indemnitee of notice of the commencement of
any action or proceeding (including any governmental action or proceeding) involving an Indemnified Liability, such Investor Indemnitee
or Company Indemnitee, as applicable, shall, if a claim for an Indemnified Liability in respect thereof is to be made against any indemnifying
party under this Article V, deliver to the indemnifying party a written notice of the commencement thereof; but the failure to so notify
the indemnifying party will not relieve it of liability under this Article V except to the extent the indemnifying party is prejudiced
by such failure. The indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires,
jointly with any other indemnifying party similarly noticed, to assume control of the defense thereof with counsel mutually reasonably
satisfactory to the indemnifying party and the Investor Indemnitee or Company Indemnitee, as the case may be; provided, however, that
an Investor Indemnitee or Company Indemnitee shall have the right to retain its own counsel with the actual and reasonable third party
fees and expenses of not more than one counsel for such Investor Indemnitee or Company Indemnitee to be paid by the indemnifying party,
if, in the reasonable opinion of counsel retained by the indemnifying party, the representation by such counsel of the Investor Indemnitee
or Company Indemnitee and the indemnifying party would be inappropriate due to actual or potential differing interests between such Investor
Indemnitee or Company Indemnitee and any other party represented by such counsel in such proceeding. The Investor Indemnitee or Company
Indemnitee shall cooperate fully with the indemnifying party in connection with any negotiation or defense of any such action or claim
by the indemnifying party and shall furnish to the indemnifying party all information reasonably available to the Investor Indemnitee
or Company Indemnitee which relates to such action or claim. The indemnifying party shall keep the Investor Indemnitee or Company Indemnitee
reasonably apprised as to the status of the defense or any settlement negotiations with respect thereto. No indemnifying party shall be
liable for any settlement of any action, claim or proceeding effected without its prior written consent, provided, however, that the indemnifying
party shall not unreasonably withhold, delay or condition its consent. No indemnifying party shall, without the prior written consent
of the Investor Indemnitee or Company Indemnitee, consent to entry of any judgment or enter into any settlement or other compromise which
does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Investor Indemnitee or Company Indemnitee
of a release from all liability in respect to such claim or litigation. Following indemnification as provided for hereunder, the indemnifying
party shall be subrogated to all rights of the Investor Indemnitee or Company Indemnitee with respect to all third parties, firms or corporations
relating to the matter for which indemnification has been made. The indemnification required by this Article V shall be made by periodic
payments of the amount thereof during the course of the investigation or defense, as and when bills are received and payment therefor
is due.

 

Section 5.04
Remedies. The remedies provided for in this Article V are not exclusive and shall not limit any right or remedy which may
be available to any indemnified person at law or equity. The obligations of the parties to indemnify or make contribution under this Article
V shall survive expiration or termination of this Agreement. Notwithstanding anything to the contrary under this Agreement or Applicable
Law, no party shall be entitled to any indemnification pursuant to this Article V (other than claims for any damages resulting from fraud)
until the aggregate amount of all such damages that would otherwise be indemnifiable to such party equals or exceeds $25,000 (the “Basket”),
at which time such party shall be entitled to indemnification for the full amount of all damages (including all damages incurred prior
to exceeding the Basket).

 

Section 5.05
Limitation of liability. Notwithstanding the foregoing, no party shall be entitled to recover from the other party for punitive,
indirect, incidental or consequential damages.

 

Article VI.

Covenants of the Company

 

Section 6.01
Registration Statement.

 

		(a)	Filing of a Registration Statement. The Company shall prepare and file with the SEC a Registration
Statement, or multiple Registration Statements for the resale by the Investor of Registrable Securities. The Company in its sole discretion
may chose when to file such Registration Statements; provided, however, that the Company shall not have the ability to request
any Advances until the effectiveness of a Registration Statement.

 

		(b)	Maintaining a Registration Statement. The Company shall maintain the effectiveness of any Registration
Statement that has been declared effective at all times during the Commitment Period, provided, however, that if the Company has received
notification pursuant to Section 2.04 that the Investor has completed resales pursuant to the Registration Statement for the full Commitment
Amount, then the Company shall be under no further obligation to maintain the effectiveness of the Registration Statement. Notwithstanding
anything to the contrary contained in this Agreement, the Company shall ensure that, when filed, each Registration Statement (including,
without limitation, all amendments and supplements thereto) and the prospectus (including, without limitation, all amendments and supplements
thereto) used in connection with such Registration Statement shall not contain any untrue statement of a material fact or omit to state
a material fact required to be stated therein, or necessary to make the statements therein (in the case of prospectuses, in the light
of the circumstances in which they were made) not misleading. During the Commitment Period, the Company shall notify the Investor promptly
if (i) the Registration Statement shall cease to be effective under the Securities Act, (ii) the Common Shares shall cease to be authorized
for listing on the Principal Market, (iii) the Common Shares cease to be registered under Section 12(b) or Section 12(g) of the Exchange
Act or (iv) the Company fails to file in a timely manner all reports and other documents required of it as a reporting company under the
Exchange Act.

 

    B-19

     

    

 

		(c)	Filing Procedures. Not less than one business days prior to the filing of a Registration Statement
and not less than one business day prior to the filing of any related amendments and supplements to any Registration Statements (except
for any amendments or supplements caused by the filing of any annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports
on Form 8-K, and any similar or successor reports), the Company shall furnish to the Investor copies of all such documents proposed to
be filed, which documents (other than those filed pursuant to Rule 424 promulgated under the Securities Act) will be subject to the reasonable
and prompt review of the Investor (in each of which cases, if such document contains material non-public information as consented to by
the Investor pursuant to Section 6.13, the information provided to Investor will be kept strictly confidential until filed and treated
as subject to Section 6.08). The Investor shall furnish comments on a Registration Statement and any related amendment and supplement
to a Registration Statement to the Company within 24 hours of the receipt thereof. If the Investor fails to provide comments to the Company
within such 24-hour period, then the Registration Statement, related amendment or related supplement, as applicable, shall be deemed accepted
by the Investor in the form originally delivered by the Company to the Investor.

 

		(d)	Delivery of Final Documents. The Company shall furnish to the Investor without charge, (i) at least
one copy of each Registration Statement as declared effective by the SEC and any amendment(s) thereto, including financial statements
and schedules, all documents incorporated therein by reference, all exhibits and each preliminary prospectus, (ii) at the request of the
Investor, at least one copy of the final prospectus included in such Registration Statement and all amendments and supplements thereto
(or such other number of copies as the Investor may reasonably request) and (iii) such other documents as the Investor may reasonably
request from time to time in order to facilitate the disposition of the Common Shares owned by the Investor pursuant to a Registration
Statement. Filing of the forgoing with the SEC via its EDGAR system shall satisfy the requirements of this section.

 

    B-20

     

    

 

		(e)	Amendments and Other Filings. The Company shall (i) prepare and file with the SEC such amendments (including
post-effective amendments) and supplements to a Registration Statement and the related prospectus used in connection with such Registration
Statement, which prospectus is to be filed pursuant to Rule 424 promulgated under the Securities Act, as may be necessary to keep such
Registration Statement effective at all times during the Commitment Period, and prepare and file with the SEC such additional Registration
Statements in order to register for resale under the Securities Act all of the Registrable Securities; (ii) cause the related prospectus
to be amended or supplemented by any required prospectus supplement (subject to the terms of this Agreement), and as so supplemented or
amended to be filed pursuant to Rule 424 promulgated under the Securities Act; (iii) provide the Investor copies of all correspondence
from and to the SEC relating to a Registration Statement (provided that the Company may excise any information contained therein which
would constitute material non-public information, and (iv) comply with the provisions of the Securities Act with respect to the disposition
of all Common Shares of the Company covered by such Registration Statement until such time as all of such Common Shares shall have been
disposed of in accordance with the intended methods of disposition by the seller or sellers thereof as set forth in such Registration
Statement. In the case of amendments and supplements to a Registration Statement which are required to be filed pursuant to this Agreement
(including pursuant to this Section 6.01(e)Section 6.01(e)) by reason of the Company’s filing a report on Form 10-K, Form 10-Q,
or Form 8-K or any analogous report under the Exchange Act, the Company shall file such report in a prospectus supplement filed pursuant
to Rule 424 promulgated under the Securities Act to incorporate such filing into the Registration Statement, if applicable, or shall file
such amendments or supplements with the SEC either on the day on which the Exchange Act report is filed which created the requirement
for the Company to amend or supplement the Registration Statement, if feasible, or otherwise promptly thereafter.

 

		(f)	Blue-Sky. The Company shall use its commercially reasonable efforts to, if required by Applicable
Law, (i) register and qualify the Common Shares covered by a Registration Statement under such other securities or “blue sky”
laws of such jurisdictions in the United States as the Investor reasonably requests, (ii) prepare and file in those jurisdictions,
such amendments (including post-effective amendments) and supplements to such registrations and qualifications as may be necessary to
maintain the effectiveness thereof during the Commitment Period, (iii) take such other actions as may be necessary to maintain such registrations
and qualifications in effect at all times during the Commitment Period, and (iv) take all other actions reasonably necessary or advisable
to qualify the Common Shares for sale in such jurisdictions; provided, however, that the Company shall not be required in connection therewith
or as a condition thereto to (w) make any change to its Articles of Incorporation or Bylaws, (x) qualify to do business in any jurisdiction
where it would not otherwise be required to qualify but for this Section 6.01(f), (y) subject itself to general taxation in any such jurisdiction,
or (z) file a general consent to service of process in any such jurisdiction. The Company shall promptly notify the Investor of the receipt
by the Company of any notification with respect to the suspension of the registration or qualification of any of the Common Shares for
sale under the securities or “blue sky” laws of any jurisdiction in the United States or its receipt of actual notice of the
initiation or threat of any proceeding for such purpose.

 

    B-21

     

    

 

Section 6.02
Suspension of Registration Statement.

 

		(a)	Establishment of a Black Out Period. During the Commitment Period, the Company from time to time
may suspend the use of the Registration Statement by written notice to the Investor in the event that the Company determines in its sole
discretion in good faith that such suspension is necessary to (A) delay the disclosure of material nonpublic information concerning the
Company, the disclosure of which at the time is not, in the good faith opinion of the Company, in the best interests of the Company or
(B) amend or supplement the Registration Statement or prospectus so that such Registration Statement or prospectus shall not include an
untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not misleading (a “Black Out Period”).

 

		(b)	No Sales by Investor During the Black Out Period. During such Black Out Period, the Investor agrees
not to sell any Common Shares of the Company.

 

		(c)	Limitations on the Black Out Period. The Company shall not impose any Black Out Period that is
longer than 30 days or in a manner that is more restrictive (including, without limitation, as to duration) than the comparable restrictions
that the Company may impose on transfers of the Company’s equity securities by its directors and senior executive officers. In addition,
the Company shall not deliver any Advance Notice during any Black Out Period. If the public announcement of such material, nonpublic information
is made during a Black Out Period, the Black Out Period shall terminate immediately after such announcement, and the Company shall immediately
notify the Investor of the termination of the Black Out Period.

 

Section 6.03
Listing of Common Shares. As of each Advance Date, the Shares to be sold by the Company from time to time hereunder will
have been registered under Section 12(b) of the Exchange Act and approved for listing on the Principal Market, subject to official notice
of issuance.

 

Section 6.04
Opinion of Counsel. Prior to the date of the delivery by the Company of the first Advance Notice, the Investor shall have
received an opinion letter from counsel to the Company in form and substance reasonably satisfactory to the Investor.

 

Section 6.05
Exchange Act Registration. The Company will file in a timely manner all reports and other documents required of it as a
reporting company under the Exchange Act and will not take any action or file any document (whether or not permitted by Exchange Act or
the rules thereunder) to terminate or suspend its reporting and filing obligations under the Exchange Act.

 

Section 6.06
Transfer Agent Instructions. For any time while there is a Registration Statement in effect for this transaction, the Company
shall (if required by the transfer agent for the Common Shares) cause legal counsel for the Company to deliver to the transfer agent for
the Common Shares (with a copy to the Investor) instructions to issue Common Shares to the Investor free of restrictive legends upon each
Advance if the delivery of such instructions are consistent with Applicable Law.

 

    B-22

     

    

 

Section 6.07
Corporate Existence. The Company will use commercially reasonable efforts to preserve and continue the corporate existence
of the Company during the Commitment Period.

 

Section 6.08
Notice of Certain Events Affecting Registration; Suspension of Right to Make an Advance. The Company will promptly notify
the Investor, and confirm in writing, upon its becoming aware of the occurrence of any of the following events in respect of a Registration
Statement or related prospectus relating to an offering of Common Shares (in each of which cases the information provided to Investor
will be kept strictly confidential): (i) except for requests made in connection with SEC investigations disclosed in the SEC Documents,
receipt of any request for additional information by the SEC or any other Federal or state governmental authority during the period of
effectiveness of the Registration Statement or any request for amendments or supplements to the Registration Statement or related prospectus;
(ii) the issuance by the SEC or any other Federal governmental authority of any stop order suspending the effectiveness of the Registration
Statement or the initiation of any proceedings for that purpose; (iii) receipt of any notification with respect to the suspension of the
qualification or exemption from qualification of any of the Common Shares for sale in any jurisdiction or the initiation or written threat
of any proceeding for such purpose; (iv) the happening of any event that makes any statement made in the Registration Statement or related
prospectus or any document incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires
the making of any changes in the Registration Statement, related prospectus or documents so that, in the case of the Registration Statement,
it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary
to make the statements therein not misleading, and that in the case of the related prospectus, it will not contain any untrue statement
of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the
light of the circumstances under which they were made, not misleading, or of the necessity to amend the Registration Statement or supplement
a related prospectus to comply with the Securities Act or any other law; and (v) the Company’s reasonable determination that a post-effective
amendment to the Registration Statement would be appropriate; and the Company will promptly make available to the Investor any such supplement
or amendment to the related prospectus. The Company shall not deliver to the Investor any Advance Notice, and the Company shall not sell
any Shares pursuant to any pending Advance Notice (other than as required pursuant to Section 2.02(d)), during the continuation of any
of the foregoing events (each of the events described in the immediately preceding clauses (i) through (v), inclusive, a “Material
Outside Event”).

 

Section 6.09
Consolidation. If an Advance Notice has been delivered to the Investor, then the Company shall not effect any consolidation
of the Company with or into, or a transfer of all or substantially all the assets of the Company to another entity before the transaction
contemplated in such Advance Notice has been closed in accordance with Section 2.02 hereof, and all Shares in connection with such Advance
have been received by the Investor.

 

Section 6.10
Issuance of the Company’s Common Shares. The issuance and sale of the Common Shares hereunder shall be made in accordance
with the provisions and requirements of Section 4(a)(2) of the Securities Act and any applicable state securities law.

 

    B-23

     

    

 

Section 6.11
Market Activities. The Company will not, directly or indirectly, take any action designed to cause or result in, or that
constitutes or might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company
under Regulation M of the Exchange Act.

 

Section 6.12
Expenses. The Company, whether or not the transactions contemplated hereunder are consummated or this Agreement is terminated,
will pay all expenses incident to the performance of its obligations hereunder, including but not limited to (i) the preparation, printing
and filing of the Registration Statement and each amendment and supplement thereto, of each prospectus and of each amendment and supplement
thereto; (ii) the preparation, issuance and delivery of any Shares issued pursuant to this Agreement, (iii) all fees and disbursements
of the Company’s counsel, accountants and other advisors (but not, for the avoidance doubt, the fees and disbursements of Investor’s
counsel, accountants and other advisors), (iv) the qualification of the Shares under securities laws in accordance with the provisions
of this Agreement, including filing fees in connection therewith, (v) the printing and delivery of copies of any prospectus and any amendments
or supplements thereto, (vi) the fees and expenses incurred in connection with the listing or qualification of the Shares for trading
on the Principal Market, or (vii) filing fees of the SEC and the Principal Market.

 

Section 6.13
Current Report. The Company shall not, and the Company shall cause each of its Subsidiaries and each of its and their respective
officers, directors, employees and agents not to, provide the Investor with any material, non-public information regarding the Company
or any of its Subsidiaries without the express prior written consent of the Investor (which may be granted or withheld in the Investor’s
sole discretion and if granted must include an agreement to keep such information confidential until publicly disclosed or 45 days have
passed); it being understood that the mere notification of Investor required pursuant to Section 6.08(iv) hereof shall not in and of itself
be deemed to be material non-public information. Notwithstanding anything contained in this Agreement to the contrary, the Company expressly
agrees that it shall publicly disclose, no later than four 45 days following the date hereof, but in any event prior to delivering the
first Advance Notice hereunder, any information communicated to the Investor by or, to the knowledge of the Company, on behalf of the
Company in connection with the transactions contemplated herein, which, following the date hereof would, if not so disclosed, constitute
material, non-public information regarding the Company or its Subsidiaries.

 

Section 6.14
Advance Notice Limitation. The Company shall not deliver an Advance Notice if a shareholder meeting or corporate action
date, or the record date for any shareholder meeting or any corporate action, would fall during the period beginning two Trading Days
prior to the date of delivery of such Advance Notice and ending two Trading Days following the Closing of such Advance.

 

Section 6.15
Use of Proceeds. The Company will use the proceeds from the sale of the Common Shares hereunder for working capital and
other general corporate purposes or, if different, in a manner consistent with the application thereof described in the Registration Statement.
Neither the Company nor any Subsidiary will, directly or indirectly, use the proceeds of the transactions contemplated herein, or lend,
contribute, facilitate or otherwise make available such proceeds to any Person (i) to fund, either directly or indirectly, any activities
or business of or with any Person that is identified on the list of Specially Designated Nationals and Blocker Persons maintained by OFAC,
or in any country or territory, that, at the time of such funding, is, or whose government is, the subject of Sanctions or Sanctions Programs,
or (ii) in any other manner that will result in a violation of Sanctions or Applicable Laws.

 

    B-24

     

    

 

Section 6.16
Compliance with Laws. The Company shall comply in all material respects with all Applicable Laws.

 

Section 6.17
Market Activities. Neither the Company, nor any Subsidiary, nor any of their respective officers, directors or controlling
persons will, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or might reasonably
be expected to constitute or result, in the stabilization or manipulation of the price of any security of the Company to facilitate the
sale or resale of Common Shares or (ii) sell, bid for, or purchase Common Shares in violation of Regulation M, or pay anyone any
compensation for soliciting purchases of the Shares.

 

Article VII.

Conditions for Delivery of Advance Notice

 

Section 7.01
Conditions Precedent to the Right of the Company to Deliver an Advance Notice. The right of the Company to deliver an Advance
Notice and the obligations of the Investor hereunder with respect to an Advance is subject to the satisfaction by the Company, on each
Advance Notice Date (a “Condition Satisfaction Date”), of each of the following conditions:

 

		(a)	Accuracy of the Company’s Representations and Warranties. The representations and warranties
of the Company in this Agreement shall be true and correct in all material respects.

 

		(b)	Registration of the Common Shares with the SEC. There is an effective Registration Statement pursuant
to which the Investor is permitted to utilize the prospectus thereunder to resell all of the Common Shares issuable pursuant to such Advance
Notice. The Company shall have filed with the SEC in a timely manner all reports, notices and other documents required under the Exchange
Act and applicable SEC regulations during the twelve-month period immediately preceding the applicable Condition Satisfaction Date.

 

		(c)	Authority. The Company shall have obtained all permits and qualifications required by any applicable
state for the offer and sale of all the Common Shares issuable pursuant to such Advance Notice, or shall have the availability of exemptions
therefrom. The sale and issuance of such Common Shares shall be legally permitted by all laws and regulations to which the Company is
subject.

 

		(d)	No Material Outside Event. No Material Outside Event shall have occurred and be continuing.

 

		(e)	Performance by the Company. The Company shall have performed, satisfied and complied in all material
respects with all covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Company
at or prior the applicable Condition Satisfaction Date.

 

    B-25

     

    

 

		(f)	No Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall
have been enacted, entered, promulgated or endorsed by any court or governmental authority of competent jurisdiction that prohibits or
directly, materially and adversely affects any of the transactions contemplated by this Agreement.

 

		(g)	No Suspension of Trading in or Delisting of Common Shares. The Common Shares are quoted for trading
on the Principal Market and all of the Shares issuable pursuant to such Advance Notice will be listed or quoted for trading on the Principal
Market. The issuance of Common Shares with respect to the applicable Advance Notice will not violate the shareholder approval requirements
of the Principal Market. The Company shall not have received any written notice that is then still pending threatening the continued quotation
of the Common Shares on the Principal Market.

 

		(h)	Authorized. There shall be a sufficient number of authorized but unissued and otherwise unreserved
Common Shares for the issuance of all of the Shares issuable pursuant to such Advance Notice.

 

		(i)	Executed Advance Notice. The representations contained in the applicable Advance Notice shall be
true and correct in all material respects as of the applicable Condition Satisfaction Date.

 

		(j)	Consecutive Advance Notices. Except with respect to the first Advance Notice, the Company shall
have delivered all Shares relating to all prior Advances, and at least 5 Trading Days shall have elapsed from the immediately preceding
Advance Date.

 

Article VIII.

Non-Disclosure of Non-Public Information

 

The Company covenants and agrees that, other than
as expressly required by Section 6.08 hereof, or, with the Investor’s consent pursuant to Section 6.01(c) and Section 6.13, it shall
refrain from disclosing, and shall cause its officers, directors, employees and agents to refrain from disclosing, any material non-public
information (as determined under the Securities Act, the Exchange Act, or the rules and regulations of the SEC) to the Investor without
also disseminating such information to the public, unless prior to disclosure of such information the Company identifies such information
as being material non-public information and provides the Investor with the opportunity to accept or refuse to accept such material non-public
information for review. Unless specifically agreed to in writing, in no event shall the Investor have a duty of confidentiality, or be
deemed to have agreed to maintain information in confidence, with respect to the delivery of any Advance Notices.

 

    B-26

     

    

 

Article IX.

Non Exclusive Agreement

 

Notwithstanding anything contained
herein, this Agreement and the rights awarded to the Investor hereunder are non-exclusive, and the Company may, at any time throughout
the term of this Agreement and thereafter, issue and allot, or undertake to issue and allot, any shares and/or securities and/or convertible
notes, bonds, debentures, options to acquire shares or other securities and/or other facilities which may be converted into or replaced
by Common Shares or other securities of the Company, and to extend, renew and/or recycle any bonds and/or debentures, and/or grant any
rights with respect to its existing and/or future share capital.

 

Article X.

Choice of Law/Jurisdiction

 

This Agreement shall be governed
by and interpreted in accordance with the laws of the State of New York without regard to the principles of conflict of laws. The parties
further agree that any action between them shall be heard in New York County, New York, and expressly consent to the jurisdiction and
venue of the Supreme Court of New York, sitting in New York County, New York and the United States District Court of the Southern District
of New York, sitting in New York, New York, for the adjudication of any civil action asserted pursuant to this Agreement.

 

Article XI. Assignment;
Termination

 

Section 11.01
Assignment. Neither this Agreement nor any rights or obligations of the parties hereto may be assigned to any other Person.

 

Section 11.02
Termination.

 

		(a)	Unless earlier terminated as provided hereunder, this Agreement shall terminate automatically on the earliest
of (i) the first day of the month next following the 36-month anniversary of the date hereof or (ii) the date on which the Investor
shall have made payment of Advances pursuant to this Agreement for Common Shares equal to the Commitment Amount.

 

		(b)	The Company may terminate this Agreement effective upon five Trading Days’ prior written notice
to the Investor; provided that (i) there are no outstanding Advance Notices, the Common Shares under which have yet to be issued, and
(ii) the Company has paid all amounts owed to the Investor pursuant to this Agreement. This Agreement may be terminated at any time by
the mutual written consent of the parties, effective as of the date of such mutual written consent unless otherwise provided in such written
consent.

 

		(c)	Nothing in this Section 11.02 shall be deemed to release the Company or the Investor from any liability
for any breach under this Agreement, or to impair the rights of the Company and the Investor to compel specific performance by the other
party of its obligations under this Agreement. The indemnification provisions contained in Article V shall survive termination hereunder.

 

    B-27

     

    

 

Article XII. Notices

 

Other than with respect to
Advance Notices, which must be in writing and will be deemed delivered on the day set forth in Section 2.01(b), any notices, consents,
waivers, or other communications required or permitted to be given under the terms of this Agreement must be in writing and will be deemed
to have been delivered (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by facsimile or e-mail if sent on a Trading
Day, or, if not sent on a Trading Day, on the immediately following Trading Day; (iii) 5 days after being sent by U.S. certified mail,
return receipt requested, (iv) 1 day after deposit with a nationally recognized overnight delivery service, in each case properly addressed
to the party to receive the same. The addresses and facsimile numbers for such communications (except for Advance Notices which shall
be delivered in accordance with Exhibit A hereof) shall be:

 

	If to the Company, to:	
    Greenrose Acquisition Corp.

    111 Broadway

    Amityville, NY 11701

    

	 	Attention:	William F. Harley III
	 	Telephone: 	(516) 307-0375
	 	

Email:
	Mickey@greenrosecorp.com

	 	 	 
	

With a copy to (which shall not

    constitute notice or delivery of process) to:
	 
	 	
    Tarter Krinsky & Drogin

    1350 Broadway

    New York, NY 10018

	 	Attention:	 Guy Molinari
	 	Telephone: 	 (212) 216-1188
	 	Email:	gmolinari@tarterkrinsky
	 	
     

	If to the Investor(s):	YA II PN, Ltd.
	 	1012 Springfield Avenue
	 	Mountainside, NJ 07092
	 	Attention:  	Mark Angelo
	 	 	Portfolio Manager
	 	Telephone: 	(201) 985-8300
	 	
    Email:
	mangelo@yorkvilleadvisors.com

	 	 
	
    With a Copy (which shall not

    constitute notice or delivery of process) to:
	
    David Fine, Esq.

    1012 Springfield Avenue

    Mountainside, NJ 07092

	 	Telephone:	(201) 985-8300
	 	Email:	legal@yorkvilleadvisors.com
	 	 

Either may change its information contained in
this Article XII by delivering notice to the other party as set forth herein.

 

    B-28

     

    

 

Article XIII. Miscellaneous

 

Section 13.01
Counterparts. This Agreement may be executed in identical counterparts, both which shall be considered one and the same
agreement and shall become effective when counterparts have been signed by each party and delivered to the other party. Facsimile or other
electronically scanned and delivered signatures, including by e-mail attachment, shall be deemed originals for all purposes of this Agreement.

 

Section 13.02
Entire Agreement; Amendments. This Agreement supersedes all other prior oral or written agreements between the Investor,
the Company, their respective affiliates and persons acting on their behalf with respect to the matters discussed herein, and this Agreement
contains the entire understanding of the parties with respect to the matters covered herein and, except as specifically set forth herein,
neither the Company nor the Investor makes any representation, warranty, covenant or undertaking with respect to such matters. No provision
of this Agreement may be waived or amended other than by an instrument in writing signed by the parties to this Agreement.

 

Section 13.03
Reporting Entity for the Common Shares. The reporting entity relied upon for the determination of the trading price or trading
volume of the Common Shares on any given Trading Day for the purposes of this Agreement shall be Bloomberg, L.P. or any successor thereto.
The written mutual consent of the Investor and the Company shall be required to employ any other reporting entity.

 

Section 13.04
Commitment and Structuring Fee. Each of the parties shall pay its own fees and expenses (including the fees of any
attorneys, accountants, appraisers or others engaged by such party) in connection with this Agreement and the transactions contemplated
hereby, except that the Company shall pay to YA Global II SPV, LLC, a subsidiary of the Investor, a structuring and due diligence fee
in the amount of $10,000, which the Investor acknowledges has been received prior to the date hereof. A commitment fee (the “Commitment
Fee”) for this Agreement shall be paid as set forth in Section 7 of the Letter Agreement dated October __, 2021 between the
parties hereto. If the Company elects to issue shares to settle the Commitment Fee (the “Commitment Fee Shares”) then
the Company shall register the resale of such Commitment Fee Shares by including them on the next registration statement, or amendment
to a registration statement, that is filed by the Company.

 

Section 13.05
Brokerage. Each of the parties hereto represents that it has had no dealings in connection with this transaction with any
finder or broker who will demand payment of any fee or commission from the other party. The Company on the one hand, and the Investor,
on the other hand, agree to indemnify the other against and hold the other harmless from any and all liabilities to any person claiming
brokerage commissions or finder’s fees on account of services purported to have been rendered on behalf of the indemnifying party
in connection with this Agreement or the transactions contemplated hereby.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

 

    B-29

     

    

 

IN WITNESS WHEREOF,
the parties hereto have caused this Standby Equity Purchase Agreement to be executed by the undersigned, thereunto duly authorized, as
of the date first set forth above.

 

	 	COMPANY:
	 	Greenrose Acquisition Corp.
	 	 	 
	 	By:	                     
	 	Name:	 
	 	Title:	 

 

	 	INVESTOR:
	 	YA II PN, Ltd.
	 	 	 
	 	By:	Yorkville Advisors Global, LP
	 	Its:	Investment Manager
	 	 	 
	 		
    By:	Yorkville Advisors Global II, LLC

	 	 	
    Its:
	General Partner

    

	 	By:	  
	 	Name: 	Matt Beckman
	 	Title:	Member
	 	 	 

 

    B-30

     

    

 

EXHIBIT A

ADVANCE NOTICE

 

GREENROSE ACQUISITION CORP.

 

	Dated:	 	 	Advance Notice Number:	 

 

The
undersigned, _______________________, hereby certifies, with respect to the sale of Common Shares of
GREENROSE ACQUISITION CORP. (the “Company”) issuable in connection with this Advance Notice, delivered pursuant to
that certain Standby Equity Purchase Agreement, dated as of October ___, 2021 (the “Agreement”), as follows: 

 

1. The
undersigned is the duly elected ______________ of the Company.

 

2. There
are no fundamental changes to the information set forth in the Registration Statement which would require the Company to file a post-effective
amendment to the Registration Statement.

 

3.  The
Company has performed in all material respects all covenants and agreements to be performed by the Company contained in this Agreement
on or prior to the Advance Notice Date. All conditions to the delivery of this Advance Notice are satisfied as of the date hereof.

 

4. The
amount of the Advance the Company is requesting is _____________________.

 

5. The
Minimum Acceptable Price with respect to this Advance Notice is _________ (if left blank then no Minimum Acceptable Price will be applicable
to this Advance).

 

6. The
number of Common Shares of the Company outstanding as of the date hereof is ___________.

 

The undersigned has executed
this Advance Notice as of the date first set forth above.

 

	 	GREENROSE ACQUISITION CORP.
	 	 	 
	 	By:	             

 

Please deliver this Advance Notice by email to:

 

Email: Trading@yorkvilleadvisors.com

Attention: Trading Department
and Compliance Officer

Confirmation Telephone Number:
(201) 985-8300.

 

    B-31

     

    

 

EXHIBIT B

FORM OF SETTLEMENT DOCUMENT

 

VIA EMAIL

 

GREENROSE ACQUISITION CORP.

Attn:    William F. Harley III

Email:
  Mickey@greenrosecorp.com

 

	 	Below please find the settlement information with respect to the Advance Notice Date of:	 
	1.	Advance requested in the Advance Notice	 
	2.	Minimum Acceptable Price for this Advance (if any)	 
	3.	Number of Excluded Days (if any)	 
	4.	Adjusted Advance Amount (after taking into account any adjustments pursuant to Section 2.01):	 
	5.	Market Price	 
	6.	Purchase Price (Market Price x 96%) per share	 
	7.	Number of Shares due to Investor	 
	 

                                                                                If there were any Excluded Days then add the following (see Section 2.01(d)):

                                                                                 

	8.	Number of Additional Shares to be issued to Investor	 
	9.	Additional amount to be paid to the Company by the Investor (Additional Shares in number 8 x Minimum Acceptable Price)	 
	10.	Total Amount to be paid to Company (Purchase Price in number 6 + Additional amount in number 8):	 
	11.	Total Shares to be issued to Investor (Shares due to Investor in number 7 + Additional Shares in number 8):	 

 

Please issue the number of Shares due to the Investor to the account of the Investor as follows:

 

Investor’s
DTC participant #:

 

ACCOUNT NAME:

ACCOUNT NUMBER:

ADDRESS:

CITY:

COUNTRY:

Contact person:

Number and/or email:

 

	 	Sincerely,
	 	 
	 	YA II PN, LTD.

 

	Agreed and approved By GREENROSE ACQUISITION CORP.:
	 
		 
	Name: 
	Title:

 

 

B-32

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00335-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00335-of-00352.parquet"}]]